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RÉSUMÉ 
Les cancers testiculaires et lymphatiques (maladie de Hodgkin's et Non-Hodgkin's) sont 
parmi les cancers les plus répandus chez les jeunes hommes âgés de 18 à 45 aps. Ce n'est 
que récemment que le cancer fut considéré comme un événement suffisamment stressant 
pour répondre aux critères diagnostics du Trouble de Stress Post-traumatique (TSPT) 
avec des taux d'incidence variant entre 1.9 et 35.1 % (Kangas, Henry & Bryant, 2002). 
Ce projet en deux volets a pour but d'explorer les symptômes de TSPT et de détresse 
reliés au cancer, de déterminer la fréquence des symptômes de TSPT chez les jeunes 
hommes atteints de cancer, d'établir une trajectoire développementale des symptômes de 
TSPT dans la première année suivant le diagnostic de cancer, d'identifier les facteurs de 
risque qui prédisent les symptômes de TSPT et de décrire les moyens de coping et de 
croissance post-traumatique des survivants. Dans la première étude, 22 survivants de 
cancer testiculaire ou lymphatique ont participés à une entrevue semi-structurée de façon 
rétrospective. Le verbatim de ces entrevues fut analysé selon la méthode d'analyse 
qualitative de Miles et Huberman (1984). La période du diagnostic fut vécue comme un 
choc et une menace s'accompagnant souvent d'anticipation anxieuse, de déni ou 
d'évitement. Les réactions les plus communes lors de la période des traitements étaient le 
désespoir et le découragement. A long-terme dans la période post-traitement, certains 
firent l'expérience d 'une réaction émotionnelle retardée et les symptômes de TSPT 
(présence accrue d'intrusions et d'évitement) devinrent plus courants. L'optimisme était 
la méthode de coping précoce la plus commune et plusieurs rapportèrent une croissance 
post-traumatique dans la période de survie à long-terme. Les résultats de cette étude sont 
conformes au modèle socio-cognitiftransitionnel d'ajustement (social-cognitive 
transition model of adjustment) (Brennan, 2001). Dans la seconde étude, des patients 
nouvellement diagnostiqués avec le cancer (n=92) et des volontaires de la communauté 
(n=88) ont été recrutés et suivis prospectivement pour une période de 12 mois. Des 
niveaux symptomatiques sévères de TSPT furent observés chez jusqu'à un maximum de 
14.3% des patients atteints de cancer et chez jusqu'à un maximum de 5.7% des . 
volontaires lors de la première année suivant le diagnostic. Des analyses de variance 
(ANOV As) à mesures répétées ont révélés des taux plus élevés de symptômes de TSPT 
sur le lES au temps 1 et 2, sur le PCL-C au temps 2, 3 et 4, de dépression au temps 2 et 
d'anxiété aux temps 1 et 2 chez les hommes atteints de cancer comparativement aux 
volontaires. Cependant, les deux groupes n'étaient pas différents quant à leur niveau de 
stress perçu et dans la qualité de vie rapportée. De plus, une augmentation significative 
des symptômes de TSPT fut observée pour les patients atteints de cancer mais pas pour 
les volontaires. Les résultats de ces études suggèrent que la détresse, sous la forme de 
dépression et d'anxiété, était élevée mais tend à diminuer avec le passage du temps. Par 
ailleurs, les manifestations précoces de TSPT prédisent fortement les symptômes de 
TSPT à un moment ultérieur et il y a une augmentation des symptômes de TSPT avec le 
passage du temps. L'évitement et le déni sont communs au moment du diagnostic, mais 
les intrusions gagnent graduellement de l'importance. Ceci pourrait indiquer qu'une 
forme de traitement cognitif de l'expérience stressante a lieu qui permettrait aux 
survivants de revisiter leurs croyances existantes et de faire l'expérience de divers 
niveaux de croissance post-traumatique. 
Mot clés: Trouble de stress post-traumatique, croissance post-traumatique, cancer, 
détresse, jeunes hommes, traitement cognitif. 
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ABSTRACT 
Testicular and lymphatic cancers (Hodgkin's and non-Hodgkin's disease) are among the 
most common cancers in young males aged 18 to 45. It has recently been acknowledged 
that symptoms ofposttr~umatic stress disorder (PTSD) may be present following a cancer 
diagnosis, with incidence varying between 1.9% to 35.1 % (Kangas, Henry & Bryant, 
2002). This project aimed to explore the cancer related symptoms ofPTSD and distress, 
to determine the frequency of PTSD symptoms in young male cancer patients, to 
establish a timeline for PTSD symptoms in the first year following a cancer diagnosis, to 
identify risk factors that were predictive ofPTSD symptoms, and to report on the coping 
and posttraumatic growth experienced by survivors. In study 1, verbatim accounts of 22 
survivors of either testicular or lymphatic cancer were collected retrospectively. 
Qualitative data was analyzed according to the Miles and Huberman (1984) approach. 
Survivors' appraisal oftheir diagnosis as a being a shock and a threat were common, as 
were and anxious anticipation, avoidance, and denial. In the treatment phase, despair and 
discouragement were most common. In the long-term, PTSD symptoms (increased 
presence of intrusions and avoidance) and delayed emotional reactions were reported. 
Optimism was common in early coping and many reported posttraumatic growth in the 
long-term survival phase. These findings were consistent with the social-cognitive 
transition model of adjustment (Brennan, 2001). In study 2, newly diagnosed cancer 
patients (n=92) and community controls (n=88) were recruited and followed 
prospectively over a period of 12 months. Severe PTSD symptoms were observed in up 
to 14.3 % of cancer patients in the first year following diagnosis, compared to 5.7% of 
controls. Repeated measure analyses of variance (ANOVAs) revealed that cancer patients 
had higher levels ofPTSD symptoms, at time 2 and 4 on the lES, at times 2, 3 and 4 on 
the PCL-C, at time 2 for depression, and at times 1 and 2 for anxiety than control s, but 
were not different in perceived stress, nor in quality of life. Furthermore, there was a 
significant increase in PTSD symptoms over time. Initial scores ofPTSD were the only 
significant predictor of PTSD at time 4. Furthermore, there was a significant increase in 
PTSD symptoms over time for the cancer group, but not for controls. Taken together 
these results suggest that di stress in the form of depression and anxiety was elevated but 
tended to diminish over time. Moreover, early manifestations ofPTSD strongly predict 
later PTSD symptoms and there was an increase in PTSD symptoms over time. 
6 
A voidance and deniai were common at the time of diagnosis, but intrusions gradually 
became more important. This may indicate a that a form of cognitive processing of the 
stressful experience is taking place and allows sorne survivors to revisit their existing life 
assumptions and experience differing Ieveis of posttraumatic grciwth. 
Keywords: Posttraumatic stress disorder, posttraumatic growth, cancer, distress, young 
males, cognitive processing 
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SECTION 1: GENERAL INTRODUCTION 
The objectives of this project are to explore the cancer-related syrnptoms of PTSD and 
distress (depression and anxiety) both retrospectively and prospectively; determine the 
frequency, evolution and risk factors for PTSD syrnptoms in young male cancer patients 
in the first year following a cancer diagnosis; and in addition to examine their experience 
of coping and posttraumatic growth. 
Approximately 40% of Canadian women and 45% of Canadian men will be diagnosed 
with cancer at sorne point in their lifetime and 1 out of every 4 Canadians will die from 
cancer (Canadian Cancer Society /National Cancer Institute of Canada [CCS/NCIC], 
2008). In 2008, nearly 30% ofnew cancer diagnoses (50 000 cases) and 18% of cancer-
related deaths (13 000 cases) will occur between the ages of20 and 59 (CCS/NCIC, 
2008). Hence, there is a growing concem to understand the psychological adjustment of 
younger cancer patients. Cancers such as testicular (TC), Hodgkin's (HD) and non-
Hodgkin's (NHD) lyrnphoma largely occur in young men in the most productive 
developmental stage of their life (i.e. raising children, building conjugal relationships, 
employrnent etc.). In Canada, there will be an estimated 3800 new cases ofNHD, 480 
new cases of HD and 890 new cases of TC in 2008 in males of aIl ages (CCS/NCIC, 
2008). The low incidence rates ofNHD, HD and TC add to the difficulties of studying 
psychosocial adjustment in this population. 
Testicular Cancer 
Testicular cancers are almost always germ cell (reproductive ceIl) tumors. There are 
two types of TC, seminoma and nonseminoma (CCS/NCIC, 2008; Gilligan, 2007). TC is 
the most common malignancy in men ages 15 to 45 and accounts for almost 25% of aIl 
cancer diagnoses in this age-range (Fossa & Dahl, 2002; Gilligan, 2007; Raemarkers et 
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al., 2002). The highest rate of five-year relative survival in Canada is for TC (96%), 
however incidence rates of this malignancy have been increasing (CCSINCIC, 2008). 
The risk factors of TC are poorly understood (CCSINCIC, 2008). Cryptorcliidism (delay 
in the descent oftesticles), abnormal development of the testicle, pers on al or family 
history of TC, age (particularly between 15 and 49) and infertility (CCSINCIC, 2008; 
Gilligan 2007) are sorne of the possible causes of TC. 
TC is most often discovered by the patients themselves as such tumors grow rapidly 
and are easily palpated. Early detection by regular testicular self-examination may curb 
disease severity (Gilligan, 2007; Moul, 2007; Simon, 2005). The most common early 
symptoms for TC are: a lump on the testicle that is almost always painless, feeling of 
heaviness or dragging in the lower abdomen or scrotum, a dull ache in the lower 
abdomen and groin (CCSINCIC, 2008). Unfortunately, TC symptoms may be 
confounded as resulting from an infection and treated ineffectively with antibiotics which 
may allow the tumor to growfor an added period oftime. 
Treatment typically includes one or more of the following: radiation, combination 
chemotherapy (carboplatin, blenoxane, etoposide and cisplatin) and surgery 
(orchiodectomy and retroperitoneallymph node dissection). Radical orchiectomy 
(surgical removal of the affected testicle) is a standard procedure of the diagnosis work-
up (CCSINCIC, 2008; Gilligan, 2007). With one healthy testicle, patients are still able to 
have erections and ejaculations, and may still be able to father children. In about 2 to 3% 
of cases, the second testicle will also develop a malignancy (Gilligan, 2007). In such 
cases, both testicles are removed and patients are infertile and experience orgasms as dry 
- -
ejaculations. Before undergoing any systematic or invasive procedure, patients are urged 
to make use of sperm banking because of the potential for temporary or permanent 
.17 
infertility following cancer treatments. There are several cancer-related causes of 
infertility: the systemic effects of the disease itself (for both testicular and lymphatic 
cancers), the surgi cal procedures (non-nerve sparing retroperitoneallymph node 
dissection, resection ofresidual node masses, removal of testes), and gonadotoxic 
chemotherapy and radiotherapy (Hartmann Albrecht, Schmoll, Kuczyk, 
Kollmannsberger, & Bokemeyer, 1999; Howell & Shalet, 2002; Naysmith, Blake, 
Harvey, & Johnson, 1998; Schrader,Heicappell, Muller, Straub, & Miller, 2001; TaI, 
Botchan, Hauser, Yogev, Paz, & Yavetz, 2000). Male cancer patients usually recover 
spermatogenesis between two to four years post-completion of cytotoxic cancer therapy, 
but it is currently impossible to predict the likelihood, extent and timing of fertility 
recovery, and up to 30% of patients may never recover (Colpi, Contalbi, Nerva, Sagone, 
& Piediferro, 2004; Giwercman & Petersen, 2000). 
The spectrum of treatment related late-effects ranges from minor complications to 
permanent and occasionally lethal sequelae (i.e. cardiac complications, the occurrence of 
a second malignancy, infertility) (Aziz & Rowland, 2003; Gilligan, 2007). After surgery, 
pain, nausea, and lack of appetite may be experienced. Radiation side-effects are usually 
mi Id and include fatigue, irritation or tendemess of the skin where the treatment was 
given. The side-effects will usually disappear when the treatment period is over and the 
normal cells repair themselves. TC responds weIl to chemotherapy. The treatment is 
outpatient for most patients and may last from six to ten months (Gilligan, 2007). 
Although healthy cells can recover over time, patients may experience side-effects from 
treatment like nausea, vomiting, loss of appetite, fatigue, hair loss and an increased risk 
of infection. High doses of chemotherapy may also kill normal blood-forming cells in the 
marrow. Blood transfusions or "blood cell growth factors" to increase red cells may be 
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needed: To improve white ceIl count the amount of chemotherapy drugs may be reduced, 
time between treatments may be increased and growth factors to increase neutrophils may 
be given. A neutrophil is a type of white ceIl that fights infection in the body. Bone 
man'ow transplantation (stem ceIl transplant) is a newer treatment option that uses a 
patient's own stem ceIls (autologous infusion) or donated stem ç:eIls (aIlogeneic 
transplant) to restore blood and immune cell formation after intense chemotherapy or 
radiation therapy (CCSINCIC, 2008). 
Lymphatic cancers 
Lymphomas are a group ofblood cancers that start in the lymphatic system. 
Lymphoma starts with a change to a type of white blood ceIl caIled a lymphocyte. The 
change of the lymphocyte causes it to become a lymphoma cell. The two most prevalent 
types oflymphoma are HD and NHD. Approximately 15 percent of people with 
lymphoma have HD; others have one ofmany different subtypes ofNHD (CCSINCIC, 
2008). The 5-year survival rate for males with lymphoma is over 80% (Raemarkers et al., 
2002) but NHD generaIly has a worse prognosis (Jemal et al. 2004). NHD is currently 
the 5th most common type of cancer across aIl age groups in Canada (CCSINCIC, 2008), 
and the second most prevalent type of cancer in 20. to 44 years of age (CCSINCIC, 2002). 
Fortunately, since 2000, mortality rates in males have shown a statisticaIly significant 
decline of 2.3% per year (CCSINCIC, 2008). 
The risk factors and causes of HD and NHD are also poorly understood and in many 
cases patients do not show any identifiable risk factors. Infections with the Epstein-Barr 
virus, the hum an T -ceIl lymphocytotropic virus (HTL V), or human immunodeficiency 
virus (HIV), family history, and age (particularly between 15 and 35 and after 60) 
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increase the probability of developing HD (Leukemia and Lyrnphoma Society, 2008). 
Exposure to pesticides, dioxins and herbicides may also increase the risk ofNHD 
(CCSINCIC, 2008). Usually the first syrnptom ofHD or NI:ID lyrnphoma is swelling of 
lyrnph nodes in the neck, arrnpit, chest, groin, or near the ears or elbows. The enlarged 
lyrnph nodes are usually painless. Other signs and syrnptoms ofHD are weight loss, night 
sweats, unexplained fever, feeling tired, lack of energy, and itchy skin (CCSINCIC, 2008; 
Leukemia and Lyrnphoma Society [LLS], 2008). 
Treatment options for lyrnphomas are chemotherapy, radiation therapy, biological 
therapy (sometimes called immunotherapy), bone marrow transplant, and peripheral stern 
cell transplant (LLS, 2008; Theodossiou & Scharzenberger, 2002). Watchful waiting may 
be recommended in slow growing NHD to avoid side-effects oftreatment until it is 
needed. Lyrnphomas make it harder for the body's immune system to fight off infections, 
and chemotherapy and radiation can create complications. A patient who has high-dose 
chemotherapy may need a stern cell transplant to strengthen the immune system. Sorne 
common side-effects from treatment for HD and NHD are: mouth sores, nausea, 
vomiting, diarrhea, constipation, bladder irritation, b100d in the urine, extreme tiredness, 
fever, cough, rash, haïr loss, weakness, tingling sensation, and lung, heart or nerve 
problems. Fertility may also be compromised temporarily or perrnanently (CCSINCIC, 
2008; LLS, 2008). 
Cancer-related distress 
20 
Psychological distress is a recognized side-effect of cancer. According to the c1inical 
Practice Guidelines in Oncology issued by the National Comprehensive Cancer Network 
(2005, p.1) distress is: 
A multifactorial unpleasant emotional experience of a psychological (cognitive, 
) 
behavioràl, emotional), social, and/or spiritual nature that may interfere with the 
ability to cope effectively with cancer, its physical symptoms and its treatment. 
Distress extends along a continuum, ranging from common normal feelings of 
vulnerability, sadness and fears, to problems that can become disabling, su ch as 
depression, anxiety, panic, social isolation, and existential and spiritual crisis. 
On average, 35% of patients suffer from elevated levels of di stress at sorne point 
during their cancer expenence (Zabora, BrintzenhofeSzoc, Curbow, Hooker, & 
Piantadosi, 2001). The literature generally suggests that breast cancer patients experience 
significant levels of depression and anxiety (Amir & Ramati, 2002; Andrykowski, 
Cordova, Studts, & Miller, 1998; Deimling, Kahana, Bowman, & Schaefer, 2002; 
Epping-Jordan et al., 1999), but sorne studies suggest otherwise (see: Stiegelis, 
Hagedoom, Sanderman, Van der Zee, Buunk, Van der Bergh, 2003). 
Cancer-related PTSD 
1 
In recent years, researchers became interested in a specifie type of distress following 
cancer diagnosis: posttraumatic stress disorder (PTSD). For the first time in the Diagnostic 
and Statistical Manual of Mental Disorders-4th edition (DSM-IV) (American Psychiatrie 
Association [APA], 1994) there is recognition that life-threatening illnesses, such as 
cancer, could be of sufficient magnitude to meet the criteria of a traumatic stressor. 
One of the peculiarities ofPTSD is that it is the only DSM-IV (APA, 1994) diagnosis for 
which diagnostic criteria inc1udes both etiological and phenomenological aspects of the 
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illness (Davidson & Foa, 1991). Indeed, PTSD's criterion A qualifies the mandatory 
stressful event and appraisals leading to symptoms of the disorder. In DSM-IV, criterion A 
is formulated as follows: 
The person has been exposed to a traumatic event in which both of the following were 
present: 
1) The person experienced, witnessed, or was confronted with an event or events that 
involved actual or threatened death or serious injury, or a threat to the physical 
integrity of self or others 
2) The person 's response involved intense fear, helplessness, or horror 
The diagnosis ofPTSD as it currently stands in the DSM-IV (APA, 1994) requires: 1) 
the identification of a catastrophic event; 2) the individual' s appraisal of the catastrophic 
event; 3) and the presence of several symptoms directly associated with the initial 
catastrophic event (e.g., nightmares that occur as part of the disorder are nightmares 
about the actual event). The list of specific symptoms for PTSD diagnosis remains 
heterogeneous and requires the presence of symptoms in each of the three major c1usters 
and inc1udes a total of 17 symptoms (DSM-IV, 1994). To receive a diagnosis ofPTSD 
one must have at least one symptom ofreexperiencing (intrusions) (i.e.: persistent and 
uncontrollable thoughts about the event, recurrent dreams about the event, physiological 
and emotional arousal upon cues resembling the event etc.) (Criterion B), three symptoms 
of avoidance and numbing (i.e. efforts to avoid thoughts, feeÜngs, conversations, places, 
and activities associated with the event, incapacity to recall important aspects of the 
event, restricted range of affect etc.) (Criterion C), anÔ two symptoms ofhyperarousal 
(i.e. irritability, hypervigilance, exaggerated startle response etc.) (Criterion D). As such, 
a person with 13 symptoms may not meet the specific criteria for PTSD and two 
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individuals with PTSD may have no common symptoms. While severe stressful 
experiences lead to high rates of diagnosable PTSD, trauma survivors without the full 
disorder can also experience high symptomatic levels of subdiagnostic distress 
(McMillen, North, & Smith, 2000). In fact, sorne researchers in the field of PTSD have 
argued that the stringency of the avoidance and numbing criterion (Criterion C) 
contributes to the low incidence rates of the disorder in sorne studies (McMillen et al., 
2000; Norris, 1992). Criterion C requires a higher number ofreported symptoms (three) 
than the other criteria, and the symptoms in the cluster are sorne of the rarest (i.e. 
numbing, amnesia) (McMillen et al., 2000; Norris, 1992). In a sample of hurricane 
victims, 83% met criterion B, 42% met criterion D but only 6% met criterion C, hence 
only 5% met the full criteria for PTSD (Norris, 1992). In a sample of earthquake 
survivors, 13% met the full criteria for PTSD, but when Criterion C was reduced from 3 
to 2 symptoms, 26% met the full criteria for PTSD (McMillen et al., 2000). 
Because the triggering event plays such a central role in the onset of PTSD, one may put 
forth the hypothesis that different triggering events may result in different profiles of 
PTSD. For example, the intrusions experienced by patients diagnosed with a life-
threatening illness may be more future-oriented than focused on the past (Kangas, Henry, 
& Bryant, 2002; Mundy & Baum, 2004). After the initial shock of a diagnosis of cancer, 
for example, patients have many threats and potentiallosses to anticipate. The 
apprehension of su ch events may intrude more consistently than intrusions regarding the 
time of the initial shock (Brennan, 2001). 
To verify if the breast cancer experience qualified as a traumatic stressor, Cordova et 
al. (2001) asked patients if the y perceived being diagnosed with and treated for breast 
cancer as a threat of death or serious injury or as a serious threat to their physical 
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integrity, and iftheir response ever involved intense fear or helplessness. There were 
61 % of participants who rated breast cancer as a traurnatic stressor. They perceived this 
event as a threat to life or to physical integrity in 80% of the cases and responses ' 
involved fear, helplessness or hOITor in 64% of survivors. 
A review by Kangas et al. (2002) of studies with breast, prostate, neck, gastro-
\ 
intestinal cancers and Hodgkin's disease patients and studies with heterogeneous sarnples 
have shown incidence rates of PTSD varying between 1.9% to 35.1 %. This variability in 
findings is due in part to the different assessrnent tools used by researchers, by the 
diversity of populations sarnpled, and by the tirne elapsed between diagnosis and the tirne 
of data collection (Kangas et al. 2002). Even years after rernission, survivors rnay still 
present with PTSD symptorns. A study ofbreast cancer patients by Alter et al. (1996) 
found that five years post-treatrnent4% ofwornen had CUITent PTSD, and 22% had 
lifetirne PTSD (a clinicallevel ofPTSD symptorns at any tirne after the traurnatic event) 
related to cancer. Other investigations suggest that the prevalence of cancer-related PTSD 
symptorns rnay be ev en higher. In a sarnple ofbreast cancer survivors, 52% of the sarnple 
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scored in the high range ofPTSD symptorns on the Impact of Event Scale (lES) (Butler, 
Kooprnan, Classen, & Spiegel, 1999). Unfortunately, rnost studies ofPTSD following 
cancer have been cross-sectional, and rnany questions rernain conceming the applicability 
ofPTSD to cancer as a stressful event. Across the cancer trajectory, which includes rnany 
potential threats and losses, it has not been weIl established wh ether PTSD symptorns are 
rnost present early post-diagnosis or in the post-treatrnent phase. However, one study 
identified the diagnosis itself as the principal stressor of the cancer experience in a cross-
sectional study with breast cancer patients (Andrykowski et al., 1998). Sorne studies have 
concluded that tirne since treatrnent is inversely related to PTSD symptorns (Alter et al. 
24 
1996; Fleer et al. in press; Kangas, Henry Bryant, 2005a). These studies provide 
important clues as to the possible course of PTSD symptoms over time. 
In a series of papers drawnfrom a single prospective study (Kangas, Henry Bryant, 
2005a, 2005b, 2005c, 2005d), there was significant decline in PTSD symptoms from 
diagnosis to 1 year post-diagnosis as measured by the Clinician administered PTSD Scale 
(CAPS), and none ofthose that had low Acute stress disorder1 scores at diagnosis 
developed PTSD at one year, pointing to the importance of early assessment ofPTSD 
symptoms following cancer diagnosis (Kangas et al., 2005a). However, this study' also 
showed that there were significantly more women than men who met the criteria for 
PTSD at six (47% vs. 13%) and twelve (42% vs. 5%) months (Kangas et al., 2005a, 
2005b). Other prospective studies pointed to a decline in PTSD symptoms in general 
(Manuel, Roth, Keefe, & Brantley, 1987) or in intrusive thoughts but not in avoidance as 
measured by the lES after diagnosis (Epping-Jordan et al. 1999). 
A number of studies and authors have noted the extensive burden that PTSD 
symptoms pose on individuals (Frueh, Cousins, Hiers, Cavenaugh, Cusack, & Santos, 
2002). PTSD symptoms are associated with a reduction in immune response, namely in 
women with breast cancer (Andersen et al., 1998), an increase in somatic complaints and 
health problems (Escobar, Canino, Rubio-Stipec, & Bravo, 1992), more emotional 
disturbance, more pain, and rendering pain resistant to treatments (Aghabeigi, Feinmann, 
& Harris, 1992). The rate ofhealth service utilization in people with PTSD (38%) is 
comparable to that found in people suffering from major depression, but higher than that 
of people with other anxiety disorders (23%) or with substance use disorder (23%) 
1 Acute Stress Disorder is a diagnosis that applies to individuals having been exposed to a traumatic event 
and who exhibit symptoms for a period of two da ys to four weeks following the event A PTSD diagnosis 
cannot be given to patients until they have exhibited symptoms of the disorder for at least one month, 
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(Kessler, 2000). Topical neurological research demonstrated a significant reduction in 
gray matter volume in the right orbitofrontal cortex (which is thought to be involved in 
the extinction of fear conditioning and the retrieval of emotional memory) of breast 
cancer survivors with PTSD compared to those without PTSD and compared to healthy 
subjects both at baseline and foIlow-up investigations (Hakamata et al. 2007). PTSD is 
highly comorbid with depression and anxiety (Amir & Ramati, 2002; Deimling et al., 
2002; Edgar, Rosberger, Nowlis, 1992; Epping-Jordan et al. 1999) and the vast majority 
of those who are diagnosed with PTSD will' also experience higher risks of suicide, 
alcohol and/or drug abuse, as weIl as other types of distress (Haber et al., 2002; Kessler, 
Borges, & Walter, 1999). Despite these facts, trauma tends to go unrecognized in most 
outpatient clinics (Frueh et al. 2002). 
There are important reasons for studying PTSD, anxiety and depression jointly. PTSD 
accompanied by depression may have a different prognosis and require different 
interventions. In a commentary on the complex relationship between PTSD and 
depression, Neria & Bromet (2000) offered four possible associations: 1) depression can 
be a risk factor for PTSD; 2) depression can be a consequence of exposure to traumatic 
events; 3) it can co-occur with PTSD; and 4) it may appear following PTSD. Distress 
symptoms (such as depression and anxiety) following traumatic exposure often share the 
same risk factors as PTSD and research has shown that the incidence of PTSD increases 
the risk for first time major depression (Breslau, Davis, Peterson, & Schultz, 2000). 
Furthermore, the overlap in quantitative measure of depression, anxiety and PTSD 
produce quantitatively high collinearity. The relationship among these variables must be 
examined concurrently to ensure further understanding ofthese interactions. 
Risk factors for PTSD 
1 
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There is a paucity of research addressing the particular psychosocial needs of male 
cancer survivors. Most research in psychosocial oncology has been do ne in samples of 
breast cancer patients or in mixed-gender samples, without clear comparisons between 
male and female samples (Andrykowsky, Brady, & Hunt, 1993; Kangas et al., 2005a, 
2005b; Stiegelis et al. 2003). However, women are twice as likely as 'men to develop 
PTSD in their lifetimes (10.4% vs 5%) even though men have a broadly higher risk of 
being exposed to traumatic events in their lifetime (Kessler, Sonnega, Bromet, Hughes & 
Nelson, 1995). There are 60.7% ofmen and 51.2% ofwomen who reported at least one 
traumatic event in their lives (Kessler et al. 1995). Yet, the higher risk of PTSD in 
women is one of the most consistent finding in the epidemiology of posttraumatic stress 
disorder (Olff, Langeland, Draijer, & Gersons, 2007). 
Particular risk factors of cancer-related PTSD are princip aIl y linked to two of the 
major symptom clusters ofPTSD: intrusions and avoidance. Most studies have used the 
Impact of Events Scale (lES) (Horowitz, 1979) as a proxy for PTSD. This questionnaire 
assesses only intrusive and avoidant symptoms. Lower age is related to increased 
symptoms of intrusions and avoidance in long-term breast cancer survivors (Butler et al., 
1999), as weIl as newly diagnosed breast cancer patients (Epping-Jordan et al. 1999). 
Other variables such as lower education (Cordova, Andrykowski, Kenady, McGrath, 
Sloan, & Redd, 1995; Epping-Jordan et al. 1995) and lower income (Cordova et al. 1995) 
are also associated with an increased presence ofPTSD symptoms in breast cancer 
patients. In a study of TC survivors (Fleer et al. in press), high scores on the lES were 
associated with being younger, single, unemployed, and treated more recently. There is 
no evidence of a relation between disease stage, or total number of treatments received 
and subsequent PTSD (Cordova et al. 2001; Kangas et al, 2002; Kangas et al. 2005a, 
2005b). 
Cognitive Processing and Posttraumatic Growth 
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Highly stressful events may overwhelm survivors (Brennan, 2001). Thus, avoidance 
may be part of the normal adaptive process that preserve a coherent mental model of the 
world, while defending against threatening and painful information that cannotbe easily 
integrated into the assumptive world (Brennan, 2001). However, while avoidance may be 
an adaptive short-term mechanism it may become counter-productive ifit goes on for too 
long as it prevents adequate cognitive processing (Brennan, 2001; McMillen et al., 2000, 
Foa, Stekee, Rothbaum, 1989; SuIs & Fletcher, 1985). 
A theme that runs across cognitive theories of healthy adaptation to extremely 
stressful events is that adjustment stems out of the repeated confrontation with the 
memories of the trauma (Brennan, 2001; Creamer, Burgess, Patti son, 1990, 1992; 
Greenberg, 1995). Positive appraisals and reappraisals of a traumatic event may protect 
against developing PTSD (Olff et al., 2007). They have been linked to faster cortisol 
habituation to subsequent stressors, indicating a greater flexibility in the system (Epel, 
McEwen, & Ickovics, 1998). Thus avoidance, more than intrusions may lead to increased 
di stress by preventi~g the direct confrontation and cognitive processing of the stressful 
memories (Creamer et al., 1992). The importance of avoidance and numbing symptoms 
in predicting the development of psychopathology is also reflected in the importance 
given to Criterion C in the DSM-IV. 
While the thoughts and memories associated with the stressful event are cognitively 
processed, they may be replaced by other adaptive schemas, which produce posttraumatic 
growth. There is a growing body of research suggesting that 60% to 90% of cancer 
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survivors experience posttraumatic growth (Collins, Taylor, & Skolan, 1990). 
Posttraumatic growth results wh en individuals having faced life crises experience a 
positive outcome (Tedeschi and Calhoun 2004). Growth may manifest itself across a 
vàriety of domains, su ch as having an increased gratitude for life, feeling like a stronger 
person, valuing deeper interpersonal relationships, developing a more meaningful 
spirituality, or experiencing a richer existence (Tedeschi and Calhoun 2004). In past years 
posttraumatic growth following exposure to extreme events has been frequently reported 
and researchers have given many formulations to this phenomenon. It can be viewed as 
positive illusions (Taylor & Armor, 1996), as a coping process (Aldwin, 1994), as a form 
of meaning-making (Park & Folkman, 1997), and as benefit finding (Affleck & Tennen, 
1996). Posttraurriatic growth may be a form of coping, an outcome on its own or both 
(Cordova, 2001). 
Posttraumatic growth occurs because events have forced an individual to revisit the 
long-held assumptions and beliefs about the self, others. and the world. lndividuals 
develop and rely on a general set ofbeliefs and assumptions about the world that guide 
their actions, and help them to understand the causes of events. This can provide them 
with a general sense ofmeaning and purpose (Janoff~Bulman, 1992). This is also 
consistent with Taylor's theory of cognitive adaptation to threatening events that predicts 
that cancer patients would attempt to cbnstrue personal benefit from their experience in 
an effort to protect self-esteem (Taylor, 1983). Wh en individuals are faced with 
threatening events, they are motivated to derive meaning from their experience as weIl as 
to maintain or enhance self-esteem in the face of any negative sequelae associated with 
the event (Taylor, 1983). This theory predicts that cancer patients would attempt;to 
construe personal benefit from their exp~rience in an effort to protect seIf-esteem (Taylor, 
1983). Psychosocial transitions and growth are also consistent with existential theory: 
being confronted with one's mortality may elicit a reevaluation and redefinition oflife 
goals and priorities, such that individuals emerge with a greater investment in and 
appreciation of life, interpersonal relationships, and spirituality and personal resources 
(Cordova et al, 2001). 
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Traumatic events may cause a discontinuity in identity because it is being seriously 
chalIenged by the extreme experience (Little, Paul, Jordens, & Sayers, 2002). Traumatic 
events shatter people's basic assuinptions about the world; they overwhelm usual coping 
methods that give people a sense of control, connection and meaning (Herman, 1992). This 
forces sufferers to reorganize their world view and to search for new meanings. PTSD 
distorts the normal appraisal process: people with the disorder see the world differently. 
There is difficulty in discriminating danger cues from safety cues as a consequence of 
, exposure to a significant stressor that is both unpredictable and uncontrolIable (Friedman, 
1997). The narrative of trauma includes a notion of trauma as a turning point: th en the 
world is expericnced as before and after the trauma (Tedeschi & Calhoun, 2004). Identity 
also includes future memories of the self, which involve the imagination of events that have 
yet to occur, they are the expectations we create for ourselves and form continuity within 
our lives (Little et al. 2002). For example, a young male who is a medical student has 
formed a future vision ofhimself as being a successful physician, a future husband to his 
girlfriend and a future father. AlI ofthese narrative identities are threatened by the cancer 
diagnosis. Growth, however, do es not occur as a direct result of trauma. It is the 
individual's struggle with the new reality in the aftermath of trauma that is crucial in 
determining the posttraumatic growth. Cognitive rebuilding takes into account the changed 
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reality of one's life after the trauma and produces schemas that incorporate the trauma. It is 
a consequence of attempts at survival (Tedeschi & Calhoun, 2004). 
Rationale and Purpose 
This project is part of a larger study examining the clinical, biological, psychosocial 
impact of disease and chemotherapy treatment effects (including those on reproductive 
functioning) in men treated for testicular or lymphatic cancer and provides a unique 
opportunity to study both retrospective and longitudinal subjective experiences of the 
particular risk factors, correlates and incidence of PTSD in young male cancer patients. 
The present study is taking place within the psychosocial arm, of this larger study, and is 
composed of two parts. In study l, retrospective accounts of the cancer experience are 
gathered from semi-structured interviews with a group oflong-term survivors. In study 2, 
a longitudinal quantitative investigation ofnewly diagnosed testicular or lymphatic 
cancer patients looks at the frequency, course ànd risk factors of PTSD symptoms. 
The main purpose of study 1 is to gather qualitative descriptions oftraumatic 
symptoms and identify recurrent themes in a sample of cancer survivors regarding 
specific aspects of their cancer experience. Particularly, the transition and transformations 
of cancer-related PTSD symptoms through time (diagnosis, treatment and long-term 
survivorship) are explored. The appraisal of the cancer experience at diagnosis, treatment 
and long-term survivorship phases are described with the goal of verifying if and what 
aspects of cancer are appraised as traumatic. AIso, the study describes carefully how 
shared manifestations of different disorders are more closely related to a specific disorder 
(i.e. anxiety) than another (i.e. PTSD) at different time points. The final goal of study 1 is 
to understand the seemingly contradictory reports of distress and posttraumatic growth 
and to bring these findings coherently within the available theoretical models of 
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adjustment. It is hypothesized that qualitative accounts from survivors will reveal 
experiences of psychological turmoil. We also expect that patients will move dynamically 
from di stress to posttraumatic growth and that appraisals and reappraisals about cancer 
will play a key role in this transition. This part of the study will facilitate the generation 
ofhypotheses regarding the development ofPTSD following cancer diagnosis. 
Qualitative research attempts to provide an understanding of the experiences, 
attitudes, beliefs and behaviours of social actors as they live through a situation (Elliot, 
Fischer, & Rennie, 1999). In data gathering and analysis, the qualitative researcher 
attempts to reflect the understanding of the participants, staying close to the perspective 
and meaning that the interviewee has provided. While it cannot provide causal 
explanations of phenomena, qualitative research can enrich understanding by providing a 
theory on observed data and by providing meaningful answers to questions under study 
(Elliot et al., 1999). Previous studies using qualitative methods have examined the 
experience of male cancer survivors to develop an understanding of the important 
domains of the experience. In a study of sexual clysfunctions in men following testicular 
cancer, qualitative analysisgenerated results not otherwise found with the use of 
quantitative self-reported questionnaires (Sheppard and Wylie, 2001). This approach has 
allowed the uncovering of marked variability in the expression of emotional reactions and 
psychological effects of infertility within a small sample of young male cancer survivors 
(Green, Galvin, Home, 2003). While PTSD has yet to be studied in this population, a 
qualitative investi'gation of the experience of testicular cancer survivors ai least 3 years 
post-treatment revealed themes of disbelief and despair, guarded optimism, "feeling 
under siege" and experiences of physical and emotional challenges (Brodsky, 1999). 
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Qualitative studies are particularly weIl suited for the investigation of poorly understood 
phenomena; by generating themes and hypotheses related to study questions. 
The purpose of study 2 is to examine PTSD symptoms in testicular and lymphatic 
cancer patients and try to establish a timeline for the emergence of PTSD symptoms in 
the first year following cancer diagnosis (time 1: diagnosis, time 2: 3 months post-
diagnosis, time 3: 6 months post-diagnosis and time 4: 12 months post-diagnosis). Study 
2 aims at identifying the frequency, risk factors, and course of PTSD symptoms. 
Psychological morbidity will be assessed to gain an understanding of the relationship 
between PTSD, depression and anxiety in this group. It is hypothesized that: a) incidence 
rates ofPTSD symptoms will be higher at all time points in cancer patients than in a 
group ofhealthy controls from the community, b) levels ofPTSD at a previous 
measuring time will highly predict CUITent levels ofPTSD, c) the highest level ofPTSD 
symptoms in patients will be at the time ofdiagnosis and will steadily decrease through 
time, d) younger age, prior history of trauma, lower education level and lower 
socioeconomic status will increase the likelihood ofPTSD symptoms, and e) PTSD will 
be highly correlated to depression and anxiety. 
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Abstract 
A cancer diagnosis can he a highly distressing experience, yet sorne survivors also 
experience positive psychosocial outcomes. This study explores the transitional processes 
and development of PTSD symptoms, appraisals, distress, coping and posttraumatic 
growth over time. Verhatim accounts of 22 survivors of either testicular or lymphatic 
cancer were gathered retrospectively. Qualitative data was analyzed according to the 
Miles and Huherman (1984) approach. Diagnosis was appraised as a shock and threat, 
and anxious anticipation and denial were common. In the treatment phase, despair and 
discouragement were most common. In the long-term, PTSD symptoms and delayed 
emotional reactions were reported. Optimism was common in terms of early coping and 
many reported posttraumatic growth in the long-term survival phase. Findings are 
consistent with the Social-Cognitive Transition model of Adjustment. Conclusion: 
While di stress is present throughout the cancer experience, sorne survivors revisit their 
existing life assumptions and experience differing levels ofposttraumatic growth. 
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Introduction 
Testicular cancer (TC) and Lymphatic cancer (LC) (Hodgkin's (HD) and Non-Hodgkin's 
disease (NHD)) are currently the two most common types of cancer in men 45 years of 
age or younger (Canadian Cancer StatisticslNational Cancer Institute of Canada, 2002, 
. Trask, Paterson, Fardig, & Smith, 2003). Fortunately, due to recent medical and 
technological breakthroughs, the 5-year survival rate for testicular cancer is 90-95%. 
1 
(Fossa & Dahl, 2002; Kaasa, Aass, Mastekaasa, Lund, & Fossa, 1991) and for 
1 
lymphomas this rate is over 80% (Raemarkers et al., 2002) but NHD generally has a 
worse prognosis (Jemal et al. 2004). As both incidence rates and rates of survival 
increase, more men will become long-term survivors of these cancers. Both cancers are 
treated with similar chemotherapy regimens, with similar side-effect profiles, inc1uding 
potential infertility, and both show excellent prognosis. Also, psychosocial outcomes are 
similar in these two cancer populations (Bloom et al., 1993). The cancer experience is an 
ongoing event associated with several potential threats and losses. The trajectory 
experience involves multiple stages as the patient passes through the possible threats of 
diagnosis, surgery, drug treatments, side-effects, and the survival and recovery period. 
Following a traumatic event it is common that an acute stress response emerges and may 
evolve into a chronic state of emotional dysregulation, but, for most, these symptoms will 
resolve. However, we lack an understanding of the developmental timeline of these 
symptoms and ofthe factors that lead to a timely retum to homeostasis following such 
potentially traumatic events. 
Unlike previous editions, the DSM-IV (American Psychiatric Association [APA], 4th 
Edition, 1994) recognizes that the diagnosis of a life-threatening illness, such as cancer, 
can be of sufficient magnitude to meet the criteria of a traumatic stressor. Presumably the 
) 
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traumatic eventin relation to cancer is the diagnosis itself. Apart from being exposed to 
a seriously stressful event, the person's subjective response to this event must have 
included intense fear, helplessness, or horror in order to qualify for a PTSD diagnosis. 
It is patients' subjective appraisals of the cancer experience that reveal when and how 
they perceive cancer as a threat. In PTSD, appraisal implies that an event is a threat, and 
a judgment of the seriousness of that threat. It includes giving a meaning to the threat and 
an emotional experience. The three symptom clusters necessary for diagnosing PTSD 
include: a) intrusions: persistent and uncontrollable thoughts about the event, b) 
avoidance and numbing: efforts to avoid thoughts, feelings, conversations, places, and 
activities associated'with the event, restricted range of affect, feeling detached from 
others, diminished interest in significant activities, and c) hypervigilance: increased 
arousal, exaggerated startle response, di ffi cult y concentrating. 
A review of PTSD in cancer populations revealed a prevalence of PTSD varying 
between 1.9% to 35.1 % (Kangas, Henry, & Bryant, 2002). In lymphatic cancer and 
testicular cancer survivors these figures are respectively 17% (Black & White, 2005) and 
13% (Fleer et al., in press). This variability in findings is due likely to the different 
assessment tools used by researchers, the diversity of populations sampled, small sample 
sizes and by the time elapsed between diagnosis or end oftreatment and the time of data 
collection. A study ofhead and neck cancer patients showed that while a small 
percent age ofwomen met the full criteria for PTSD 12 months post-diagnosis (14%), 
( 
these were the same patients who had met criteria at 6 months post-diagnosis (Kangas, 
Henry, & Bryant, 2005). There were no new cases ofPTSD at 12 months (Kangas et al., 
2005). These studies point to the pervasiveness of early PTSD manifestation and the need 
to investigate early PTSD manifestations in order to uncoverfactors that lead to 
unremitting (chronic) forms of the disorder over time. 
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General distress is a common side-effect of cancer. In the case ofHodgkin's and non-
Hodgkin's lymphoma patients, elevated distress was present in 37.8% and 36.6% 
respectively, placing these cancers as the 3rd and 5th most distressing types of cancer after 
1ung, brai n, and pancreatic cancers (Zabora, BrintzenhofeSzoc, Cm:bow, Hooker, & 
Piantadosi, 2001). While Zabora et al. (2001) did not provide similar norms for testis 
cancer patients, Bloom et al. (1993) found no significant differences on psycho10gical 
outcomes and distress in a comparative study oftesticular cancer patients and Hodgkin's 
lymphoma patients. Given that PTSD is highly comorbid with depression, anxiety and 
other types of di stress (Amir & Ramati, 2002; Deimling, Kahana, Bowman, & Schaefer, 
2002; Edgar, Rosberger, & Nowlis, 1992; Epping-Jordan etaI., 1999), symptoms ofthese 
disorders are likely to be elevated in young males with cancer. The overlap between these 
disorders is huge. When scales of depression, anxiety and PTSD are given, they always 
correlate highly, and thus can tell us little about the differentiation among these disorders. 
For example, "markedly diminished interest or participation in significant activities" is a 
symptom frequently observed in major depression; however in PTSD this diminished 
interest appears only following the stressful event. To give another illustration, "di ffi cult Y 
falling or staying asleep" is a symptom of primary insomnia, generalized anxiety disorder 
and major depression, to list a few; again in PTSD sleep disturbances are directly 
attributable to the initial stressful event. Qualitative investigations are needed to describe 
the co-occurrence of these disorders and perhaps to clarify when a symptom is a property 
of one specifie disorder versus another. 
38 
Despite the evidence for di stress following cancer, there is a growing body of research 
that has explored the positive benefits that may result from being confronted with a 
traumatic event (Jaffe, 1985; Tedeschi &, Calhoun, 2004). In the are a of psychosocial 
oncology, despite the hardship of a cancer diagnosis, sorne survivors experience . 
posttraumatic growth, su ch as growth in relating to others, spiritual change, and greater 
appreciation oflife (Andrykowsky, Brady, & Hunt, 1993; Carver & Antoni, 2004; 
Cordova, Cunningham, Carlson, & Andrykowski, 2001). Tedeschi and Calhoun (2004, 
p.1) have provided the following definition of posttraumatic growth: 
Posttraumatic growth is the experience of positive change that occurs as a result 
of the struggle with highly challenging life crises. It is manifested in a variety of 
ways, inc1uding an increased appreciation of life in general, more meaningful 
interpersonal relationships, an increased sense of personal strength, changed 
priorities, and a richer existential and spirituallife. 
Posttraumatic growth is a possible out come of adapting to traumatic events. In 
contrast to coping mechanisms, posttraumatic growth is an ongoing process that gives 
sense to the experience. There is a discontinuity in time as life is perceived as before 
versus after the trauma. The present study retrospectively explores the transition and 
transformations of cancer-related PTSD symptoms through time (diagnosis, treatment 
and long-term survivorship) and describes the appraisal of the cancer experience at 
diagnosis, treatment and long-term survivorship phases with the goal of verifying if and 
what aspects of cancer are appraised as traumatic. AIso, the study describes how shared 
manifestations of different disorders are more c10sely related to a specific disorder (i.e. 
anxiety) than another (i.e. PTSD) at different time points. The final goal ofthis paper is 
to understand the seemingly contradictory reports of distress and posttraumatic growth 
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and to bring these findings together coherently within the available theoretical models of 
adjustment. We expect that patients will move dynamically from di stress to 
posttraumatic growth and that appraisals and reappraisals about cancer will play a key 
part in this transition. 
Methods 
Study Design and procedures 
This qualitative study employed semi-structured individual interviews with male cancer 
survivors. Interviews were approximately 90 minutes and were conducted in English or 
French by trained interviewers. The team of interviewers was composed of four graduate 
students in psychology. Verbatim transcription of the interviews was performed by the 
interviewers and a paid research assistant. Ethics approval was obtained through a 
university institutional review board prior to the beginning of the study. Written consent 
was also obtained from each participant. The sample consisted of 22 males, TC (n=12) 
and LC (Hodgkin's Lymphoman=9; Non-Hodgkin's Lymphoma n=l) survivors. Cancer 
survivors were recruited through referrals from hospitals and private practices in the 
Montreal area (Canada, Province of Quebec). Patients were identified by physicians from 
two university hospitals in large urban area and subsequently recruited by a research 
coordinator once they met eligibility criteria. Inclusion criteria in this study were: having 
received a diagnosis of testicular cancer, Hodgkin's or Non-Hodgkin's lymphoma, being 
at least 1-10 years post completion of treatment, having received chemotherapy as part of 
their treatment regimen, and being between 18 to 40 years old at time of initial cancer 
diagnosis. In this study internaI diversification was accompli shed by selecting survivors 
who were between one to ten years post-completion of cancer treatments and ages 18 to 
40 at the time of diagnosis, thus allowing for assessment of di stress and coping at 
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different stages of survivorship and developmental maturity. InternaI homogeneity of the 
sample was achieved by selecting only survivors who had undergone gonadotoxic 
chemotherapy treatments for TC or LC. Patients were recruited until data saturation was 
reached, in other words until the addition of novel interviews only reiterated information 
th-at had already been collectedin prior interviews without adding any novel information. 
Data saturation was reached after 15 interviews. However, we proceeded with 
recruitment to inc1ude five more Hodgkin's disease survivors and one Non-Hodgkin's 
disease survivor to increase internaI diversification. Demographic data was gathered prior 
to the interview. 
This project is part of a larger study that explored communication between health care 
professionals and patients concerning fertility issues, long-term adaptation, as well as the 
relationship between psychosocial adjustment, informational needs and communication 
processes surrounding disease and its side-effects in young men diagnosed with testicular 
or lymphatic cancer and at risk for infertility. These questions were elaborated from the 
literature, a pilot qualitative study and a consensus among two c1inical psychologists and 
a urologist/reproductive specialist, all of whom were experienced in psychosocial 
oncology research and practice. Also as coding and analysis of interviews evolved, 
additional questions were inc1uded in the interview guide to validate and explore the new 
information emerging from the coding. As such, the participant's description oftheir 
psychological adjustment was incorporated as probes and questions in the interview 
guide as the project evolved. Interviews consisted of open-ended questions and specific 
probes regarding four major domains a) the general experience of cancer (i.e.: What was 
your reaction to the cancer diagnosis?, What was your experience in terms of treatment 
and side-effects?); b) the communication surrounding fertility related issues (i.e.: When 
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was i nferti lit y first brought up?); c) the psychological impact of cancer and 
chemotherapy induced i nferti lit y and sexual dysfunctions (i.e: Did you avoid the topic of 
cancer at aIl or avoid reminders ofit? Did you react with intense fear at any point?); and 
d) patient needs regarding effective communication around fertility issues (i.e.: What 
would help patients feel more comfortable, better prepared and more efficient in 
discussing infertility issues in the future?). The current study was particularly focused on 
the first and third interview domains, specifically data reflecting PTSD, di stress 
(depressed mood and anxiety), posttraumatic growth and coping. 
Data analysis 
Interviews were audio taped, transcribed verbatim, and imported into N'Vivo 2.0 
software. The data was gathered and analysed according to the Miles and Huberman 
(1984) mixed approach. This approach consists ofthree flows of analysis: data reduction 
into theme codes, data display into tables, and conclusion drawing and verification. This 
particular study places itselfbetween the post positivist and the constructivist paradigms 
(Ponterotto, 2005). The mixed approach aims at elaborating a systematic (but not 
necessarily exhaustive) description and a theory about a phenomenon. This data analysis 
method has proven rigorous and has already been used by researchers in psychosocial 
oncology (Thewes, Butow, Girgis, & Pendlebury, 2004; Thewes, Meiser, Rickard, & 
Friedlander, 2003) and proves to be particularly suited for the study ofnew and poorly 
understood phenomena. 
In the first step of analysis, similar themes that emerged from the narrative text 
were regrouped into categories (units of analysis). Similar themes were grouped into 
overarching trees (metacodes) and subcategories ofthese metacodes were placed in 
branches under these, themes having no apparent relation to other categories were kept 
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separately. The first interview was coded by a team oftwo members from the research 
group and codes were elaborated through discussion and agreement on themes. The 
second interview was coded by another team oftwo cod ers using the initial framework 
developed by the two other coders. Coders then met with the research team as a whole to 
refine the coding framework and achieve consensus. Once that was established, the 
coders proceeded to the coding of the remaining interviews. New codes were added as 
new themes emerged and the coding team met frequently together with the whole 
research team to achieve inter-coder consensus. Codes retlected categories set a priori 
from the interview package, from Othe literature reviewed and most importantly from the 
themes that emerged from the data. Coders also kept detailed memos, résumés and field 
notes during this process. Analyses continued until saturation was established and no new 
themes emerged from the data. Once the initial co ding was performed, the first author of 
this study proceeded to a more in-depth recoding of categories of interest for the present 
study. For example, under the category of di stress at diagnosis, the first author proceeded 
to refining subcategories of distress symptoms. Once the coding was fini shed the first 
author proceeded with the next analytical steps. 
In the second step of analysis, data display, the narrative text now broken down 
into codes was displayed in either tables or matrices that allowed for the categorization 
of large sum of data .into manageable amounts of information (Miles & Huberman, 
1984). In the present study, three types of matrices were used: a) checklist matrices, 
which is a table that may contain a scaling function (i.e. not at aIl, somewhat, quite a bit, 
very much) and allows to assess to presence of specific elements from the participants 
verbatim; b) time-ordered matrices: patient's experience is entered in a table arranged 
following a time sequence to see if a reported change occurs and c) conceptually 
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clustered matrices, which cluster research questions that belong together to see possible 
links between them. We used checklist matrices to verify and count the presence of 
distress and PTSD syrriptoms according to the DSM-IV-TR (American Psychiatrie 
Association [APA], 4th Edition, 1994). We used time-ordered matrices to gain a 
temporal sense of distress symptoms within and across each individual over the key time 
points of diagnosis; treatment and long-term survival. We used conceptually clustered 
matrices to display logical patterns and associations between themes that seemed to 
belong together. 
In the third step, conclusion drawing and verification, a number of strategies were 
used to confirm interpretation, avoid biases, and insure that conclusions are well founded. 
The goal is to insure that interpretation of the data is valid, reproducible and accurate 
(Huberman & Miles, 1991). The strategies most applicable to the present study included 
search for plausibility, regrouping variables, looking for patterns, and identifying 
relations between variables (Huberman & Miles, 1991). We also sought to identify 
whether a larger conceptualization or existing theory of adjustment to illnesses could help 
organize the findings and provide a conceptual and theoretical framework that would lend 
greater plausibility to the results. This strategy of achieving theoretical or conceptual 
coherence is also described by Miles and Huberman (1991). 
Findings 
Sample characteristics 
At the time of the interview, the age of participants ranged from 20 to 54 years 
(mean = 32.7), and at the time of diagnosis the age range of participants was 18-41 years 
(mean = 26.4). Time since diagnosis was on average 6.3 years (range =1-10). Most of the 
participants were currently employed in full-time work (n=20), one was retired and one 
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was ternporarily not working. With regards to farnily incorne: nine patients had an 
incorne of $59000 or less, four had an incorne between $60000 and $99000 and eight had 
an incorne of over $1 00000 (one participant refused to answer). At the tirne of their 
diagnosis, seven participants were single, five were rnarried, two were in a cornrnon-Iaw 
union, three were in a long-term relationship, two were in a recent relationship, one was 
divorced and one was widowed. A1122 survivors had received chernotherapy. Three 
Hodgkin's lymphorna survivors received chernotherapy alone. Nine testicular cancer and 
three Hodgkin's lymphorna survivors received a cornbination of surgery and 
chernotherapy. Three testicular, one non-Hodgkin's lymphorna and three Hodgkin's 
lymphorna survivors had chernotherapy, surgery and radiotherapy. To understand the 
genesis and possible transitional processes of PTSD symptorns, distress, coping and 
posttraurnatic growth qualitative thernes were organized across three areas over the 
cancer trajectory: diagnosis, treatrnent and long-term survival phases. In table 1, the data 
is organized according to this tirneline, and illustrates how symptorns evolve, appear or 
disappear frorn one phase to the next. 
Psychological reactions at diagnosis 
ln terms of initial appraisal of the stressful event of the cancer diagnosis, the 
subjective criteria of fear, horror and helplessness of PTSD were investigated. When 
asked to recall their initial psychological reaction wh en the cancer diagnosis was first 
announced, alrnost half of survivors rnentioned they experienced shock, or a sensation 
akin to depersonalisation: 
Yeah, it was like 1 was watching and 1 wasn't in the roorn. ( ... ) She was just 
giving me aIl this information and rny rnouth was just open like a deer in the 
headlights. She was telling it to me, and she was repeating it, but 1 didn't 
understand it. That meeting was a little bit scary. Is this real? It's like you're 
watching it on TV. 
Survivors had not expected their diagnosis to be so serious, they expected a benign 
infection or something of the sort; they were taken by surprise because of their relative 
young age. Yet, there were survivors who did anticipate the diagnosis of cancer and the 
news was a confirmation ofwhat they had feared. "To me it wasn't a surprise. 1 had 
pretty much expected it to be cancer." 
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In a similar vein, the fear of death and a sense of foreshortened future were themes 
described by several participants. Nonetheless, there were about as many survivors who 
recalled having been immediately reassured by their physician and felt no fear of dying. 
In spite ofthis, in a more general manner, at the time of diagnosis survivors reported 
having felt a fear of the unknown (being unfamiliar with medical treatments and 
procedures, having to rearrange their lives, etc.) feeling apprehensive about the future and 
possible medical problems. These themes also point to an appraisal of the diagnosis with 
helplessness and horror, patients describe a feeling ofbeing afraid and unable to manage 
the situation: 
WeIl it's mostly fear, fear of the unknown. You don't know what is coming up. 
( ... ) In this case for me it was a total void, l've never had someone close to me 
who had cancer, weIl yes, from far, far removed you hear things, but that's what 
is scary, you don't get real feedback from people you've known, you just get the 
horror movies that are on television. And it has not been a long lime since people 
recover from cancer. In aIl the stories you've heard before, weIl it's people dying, 
it is people who don't have any more hair, that are bony, and it's the hell of 
chemotherapy, and the hell of cancer. It's aIl of that that you see coming down 
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without you having nothing to hold on to ... about the truth ofwhat it is because 
you have no truth and there is no one around you that can help you. 
Thinking about the cancer diagnosis was emotionally painful; many stopped 
themselves from thinking about it because they reported it had a negative effect on them. 
Similarly, sorne survivors recalled a blunted emotional reaction and others recalled 
having experienced denial in the initial phase following the cancer diagnosis: 
1 didn't feel as much emotion as you might have thought, 1 didn't start to cry, 1 
didn't start to worry, it was just like a ... from then on l've put one sorne sort of.. 
you know a sheet (curtain) to hide from my emotions and l've never felt any 
emotions after that for about another year. 
Few PTSD symptoms were immediately apparent at the time of diagnosis. Symptoms 
\ 
of avoidance were brought up by a minority of survivors. Initial reaction were more 
c10sely akin to denial than to avoid~mce, with patients'experi~mcing much of a shock, for 
, 
these patients having conversations about the cancer was out of the question and they 
c1aimed they had to let sorne time go by before they could address the topic. One person 
reported intrusive thoughts, mostly in the form of anxious worry about future physical 
appearance and the ability to perform sexually in the future. This survivor explained that 
he dealt with these recurring thoughts by avoidance. There was one survivor who 
experienced nightmares related to the cancer diagnosis, but there were no reports of 
intrusive thoughts in the, form of reliving the cancer diagnosis: 
Mostly about that, it was and it was extremely depressing, so 1 just, you know, put 
it out of my mind, and again right after the surgery when things did not look 
normal it was like what if! can't perform anymore, what ifyou hear aIl kinds of 
stories about, you know what happens and aIl kinds ofthings like that. It's 
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something that you just don't want to think about. It was very scary and for me 1 
guess the best way to de al with it was just to stop it. A void thinking about it and 
you're not doing yourself any good until a certain amount oftime happens and 
th en seek professional help if necessary. Other th an that: just stop it! 
Survivors talked about the cancer diagnosis as a life-altering experience. AIso, sorne 
stated that they experienced a form of existential crisis, questioning the reason why they 
were hit by cancer. For sorne patients, the result ofthis self-questioning led to early 
acceptance of their illness: 
1 used to think like weIl why? Like l'm 25 years old and l'm in good shape why 
would this happen to me, 1 went through that whole thing ... it's not fair ... why 
me? Then it occurred to me ( ... ) weIl you know what, to somebody else l'm 
someone ... you know you always say it only happens to other people, weIl to that 
person over there l'm other people, to you l'm other people, so 1 kind ofthought 
like it's silly for me to put myselfthrough that type of torture ... like asking myself 
that question ... why me when it's going to happen to somebody and to aIl these 
other people you're other.people, you think it only happens to other people, weIl 
they think the same thing, at that point 1 just kind of 1 accepted it. 
ln addition to PTSD symptoms, survivors reported many manifestations of distress, 
they talked about sadness and depressed mood in this period. Survivors recalled having 
outburst oftears, feeling overwhelmed by a mix of emotions (anger, fear, sadness, and 
others) and feeling that others could move on with their lives but not them: 
1 started crying and it was kind of very fast in my mind, 1 was trying to figure out 
aIl the implications of it ( ... ) 1 cried and 1 realized ( ... ) the next day 1 would not 
be doing what 1 thought 1 would be doing. 
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Psychological reactions during treatment 
During the treatment phase shock receded and gave way to other types of PTSD 
manifestations. A voidance of'reminders of cancer became more prominent at this point 
with more participants recalling this symptom. Participants avoided conversations and 
reminders of cancer suc.h as watching movies depicting cancer patients, and sorne 
avoided asking questions or gaining extra information about their cancer because they 
thought they would not know how to interpret it. One survivor also mentioned that being 
rushed through the process of treatment and the structured administration of 
chemotherapy prevented him from processing the experience emotionally; he qualified 
this occurrence as a good thing, because it allowed him to avoid dealing emotionally. 
Likewise, sorne openly denied that cancer had an emotional impact on them: 
1 would say definitely that 1 would, whether it was consciously or 
subconsciously, avoid sorne things yes, 1 would, and 1 think also now that 1 think 
a bit there's also that typicallike male macho thing where 1 was thinking also that 
you know what 1 can handle this 0!1 my own, 1 don't need any help ... you know 
psychologically and physically where 1 thought that 1 could handle it on my own. 
Sometimes 1 thought 1 could and other times not so much. 
Recurring intrusive thoughts were still infrequently reported, while the presence of 
l 
nightmares was reported by the same individual as at diagnosis. Another category of 
PTSD symptoms made its appearance at this time: hypervigilance in the form of 
excessive monitoring of symptoms and going for extra medical check-ups was mentioned 
by one survivor. Content of cancer-related anxiety was diverse and wide-reaching. A 
strong apprehension about the future was an issue for numerous participants. There was 
worry about the disease and its possible complications, nervousness and stress before 
chemotherapy rounds, being worried about the impact on loved ones and the anxiety 
about the financial burden associated with being sick. 
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During the treatment period depressed mood was the most salient di stress 
symptom and was reported to a larger extent than other PTSD symptoms with more than 
half of survivors making mention of depressed mood in the interviews. for several 
survivors depressed mood was synonymous with despair during the treatment phase. It is 
noteworthy that the treatment period is the only time point where survivors recalled 
feelings of despair. These survivors had periods when they thought they would never 
recuperate; they thought death .\Vas near or that the y would never be able to enjoy a 
healthy life again. "Getting up in the morning as if you had not slept for two days ... 1 
sometimes had the impression that it wouldn't end. 1 asked myselfwhen 1 will ever be 
able to recuperate?" 
Survivors also admitted having had thoughts of death during treatment and having had 
such difficulty that they reached a point where they did not care ifthey lived or not. In 
addition, a few said that ifthey had a cancer recurrence, they would rather die than go 
back to chemotherapy. "1 would not go through that again. If it cornes back, l'm going to 
die right away. 1 will not go through that again it is too hard emotionally." 
Post-treatment and long-term psychological impact 
We also questioned participants about the impact of cancer after the end of treatment 
and through the long-terrn survivorship phase. Following treatment, there was an increase 
in the salience and diversity of reported PTSD symptoms and in the number of survivors 
who experienced them. When asked about the long-terrn emotional or psychological 
impact of cancer a few survivors spontaneously said they suffered sorne type of delayed 
emotional reaction or posttraumatic stress. "It took a good year, they call it posttraumatic 
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stress something, because a year after, when everything was over and things are supposed 
to go weIl, when they gave me the OK everything is good, that's when it hit me." "No, 
during the treatments 1 still hadn 't accepted that 1 had it. It hadn 't sunk in that 1 had 
cancer. 1 only accepted 1 had cancer once the last treatment was done." 
Furthermore, avoidance of reminders of the illness was the most often reported PTSD 
symptom in the long-term survivorship phase. AIso, avoidance became a conscious 
process, a volitional action, which differed from the sense ofunconscious denial 
following the shock of diagnosis. About half of the participants said they would either 
avoid conversations, places, images or things that reminded them of the cancer 
experience. "1 press the mute button if! see a commercial that talks about that. 1 don't 
like to hear about it so much." "Right now, in my head l'm trying to think that 1 was 
never sick. Even though 1 meet people 1 just don't mention that 1 was sick, except trying 
to forget about it." 
Symptoms of intrusions in the form of repeated unpleasant thoughts appeared with 
more importance at the end of treatment. Survivors recalled having thoughts of cancer 
everyday, "seeing" cancer everywhere, and thinking about it when they didn't mean to: 
It's clear that you can't forget it. There was a time where there wasn't one day 
where 1 didn't think about it ( ... ). The first times you have a headache: its brain 
cancer. You know, your back hurts and that's it: your tumor)s back. 1 had an 
episode recently where 1 had pain in my abdomen and 1 was really scared, 
because the fear isn't the same because of the fact that 1 have kids now. 
The previous quote poignantly exemplifies the hypervigilance that many survivors 
shared after cancer and increased fear about the future and the possible secondary 
impacts of cancer on their lives. Specifically individuals mentioned a fear ofrecurrence 
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and mentioned a fear about possible secondary impact of cancer on their lives such as 
limiting their parenthood years or general activities. Survivors who worried about 
recurrence shared that they could not get closure, that nothing could reassure them about 
the future, especiallyat a time when the medical team was no longer following them 
closely. These were additional concems that appear only once the cancer episode is in 
remission: 
Weil the minute you take a shower and you're washing your hand and you feel a 
little lump in the back, right away 1 go oh, is it back? So it's the fear of 
recurrence? Oh, yeah ... big time. Oh yeah. Since the end of the treatment the fear 
ofit coming back definitely ... it's a big fear. 
Sorne survivors reported emotional numbing, feeling detached from the experience, 
and one survivor reported trouble remembering important parts of the experience. While 
alcohol and drug abuse are not part of the classic PTSD criteria, substance abuse is a 
highly prevalent comorbid condition to PTSD (Kessler, Sonnega, Bromet, Hughes, & 
Nelson, 1995). Sorne survivors who linked the substance abuse to a process of emotional 
numbing reported these behaviors; they describe it as an illustration ofhow drastically 
they were affected by the cancer experience: 
1 realized that 1 was at the point where 1 was doing myself more harm than good. 1 
had gone through ail ofthat [cancer treatment] and now 1 was self-destructing, 
you know 1 mean ev en my friends told me. He said to me, you passed 1 year, you 
passed through that, you were strong, you were confident and then after three 
years and a half you are cured and you start doing ... you are killing yourself. l'm 
going to be honest (1 used) a bit of drugs, a bit of alcohol and the type of recourse 
that people use sometimes to forget. 
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In tenns of distress, disturbed mood was still present for sorne survivors; sorne had 
thoughts of death and one said that he would rather die than go back through cancer-
treatment. In our analysis of aIl distress symptoms reported from the period of diagnosis 
to the long-tenn survivorship, we found other psychological reactions reported less often. 
Throughout the experience sorne survivors felt concem about changes in body image, 
sexual functioning and identity. Sorne reported 10ss of self-esteem, 10ss of masculinity, 
anger, and worry about the repercussions of the cancer diagnosis on loved ones. 
AdditionaIly, mental fatigue, boredom during treatment and anticipatory nausea during 
the treatment period were mentioned. FinaIly, sorne survivors also voiced worries related 
to possible infertility at the various stages ofthe cancer experience (see: Robitaille et al., 
under revision). Despite the hardships of cancer, the presence of PTSD and distress 
symptoms, many survivors specifically reported a good general adaptation in the long-
tenn post-treatment phase. 
Coping 
Most survivors were eager to discuss their coping mechanisms. While not central to 
this study, these descriptions help to further elaborate the relationships among PTSD, 
distress and posttraumatic growth. During the interviews and analysis ofresults it became 
apparent that aIl survivors were inclined to share how they naturally coped with cancer 
and how, for most, their lives were changed for the better after its treatment. Survivors 
reported that they used various coping strategies. The most often reported coping 
mechanism was optimism. Nearly.every survivor interviewed said that keeping a positive 
spirit from the moment of diagnosis helped them to cope with the cancer experience. 
There were many participants who recalled being self-confident and focusing on positive 
future plans. AIso, a number of survivors said that the reassurance provided by their 
health care professional about the prognosis of their disease helped them to stay 
optimistic: 
Yeah it's a mental combat to keep my moral up and maintain hope to not let 
yourself go into self-pity. That's the worse thing you can do, and not just for 
cancer, for anything really. It applies to life in general. 
Survivors also coped actively by seeking social support and by keeping busy. 
Survivors said that talking about the experience to others helped them cope, and were 
grateful for having received good support from family, friends or health care 
professionals. In contrast, sorne survivors tried to keep a strong front in public and tried 
not to let others see that they experienced distress. In many instances, this theme 
resembled strongly the issue of avoidance of reminders of the illness already presented 
under the rubric of PTSD symptoms: 
53 
1 think 1 am able to control it rather weIl, and l'm not a very emotional person. 1 
don't show it too much, 1 try not to show, especially when 1 had guests, and these 
things ... 1 kept them for myself 1 think. And when the people left, when 1 was 
al one sometimes 1 found it hard, because it was then that it would hit me and 1 
knew there was no one around so 1 didn't need to be strong. 1 didn't need to show 
them that 1 was able to make it, 1 was alone. It was harder 1 think because then 1 
would let go. 
Staying bus y and trying to maintain a "normal" life helped a quantity of survivors 
cope. These survivors said they kept going to work, maintained sorne social activities and 
exercised while they were cancer patients. Survivors described other coping strategies 
such as seeking professional help in counseling, acceptance of the disease, active 
information seeking about the disease, and sorne coped with a good sense ofhumor: 
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So you cope with humor also a little bit? Survivor: Yeah ... like a lot of the time 
people used to ask me like ... how come your hair is so short and you don't havè 
eyelashes and eyebrows so 1 say yeah 1 swim a lot, so l'ni on the swimming team. 
Also because there are weIl known personalities who were diagnosed with either 
testicular or lymphatic cancer, sorne survivors reported they compared themselves to the 
experiences ofthese men: 
Look at Mario Lemieux, he had Hodgkin's disease, he kept playing ... he missed 
sometime, but he never lost aIl ofhis hair, he kept playing ( ... ) Lance Armstrong 
had testicular, but he also had it in the brain too didn't he ( ... ) and Saku Koivu his 
was Non-Hodgkin's and what he had made what 1 had look like a bad cold. 
Posttraumatic growth 
One of the strongest emerging themes from the interviews was that of posttraumatic 
growth, almost aIl of the survivors reported that the cancer experience had brought 
positive benefit. for them. More specificaIly, participants said they experienced a positive 
change in personality. They reported feeling more mature, more sensitive, more empathy 
for hum an 'suffering and feeling like a stronger person. AdditionaIly, sorne of these 
participants said they had a greater appreciation for life, and had reevaluated their life 
priorities so that they did not let themselves get upset so much for trivialities anymore. 
One survivor also mentioned he now took more time for himself since the cancer 
expenence: 
It is when health is threatened that we realize its value, its true value. Also, to 
appreciate the good times, life's little happinesses, it's not the quest for something 
ultimate ... it's the sum of little things. Also being more aware of others' 
hardships. 
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The cancer experience also strengthened sorne relationships and made survivors 
reevaluate who their real friends were: 
It was a test, but it absolutely strengthened our relationship, especiaIly going 
through the chemotherapy ... such as the vomiting, the whole hospital ordeal ... ' 
My wife was always there and very supportive and would be leaving work to be 
with me. A lot oftimes 1 ev en said, don't worry about it, you can go to work, but 
she wouldn 't hear of it, so that helped a lot and 1 think that brought us to another 
level, it strengthened our bond. 
Creating strong positive relations with others became more important and one survivor 
ev en offered to become a mentor for others faced with the same cancer as him: 
Like myself, 1 gave my name (to the hospital) so that if ever someone had the 
same cancer as me and they think it would be helpful that 1 talk to him, weIl you 
calI me, and anytime 1 will go because 1 think that that is important." 
ln sum, the suddenness of the cancer diagnosis for young individuals may leave them 
unprepared to deal with cancer and the side-effects of its treatment, as weIl as the 
appearance of di stress symptoms and PTSD. However, in the survival phase, the quality 
of the experience is not completely negative, as clearly many report positive outcomes. 
Discussion 
This study explored the cancer-related symptoms ofPTSD and di stress (specificaIly 
symptoms of depression and anxiety), and reported on the coping and posttraumatic 
growth experienced by survivors. The results from this study are consistent with the 
social-cognitive transition model of adjustment (Brennan, 2001) and the literature on 
posttraumatic growth (Tedeschi & Calhoun, 2004). 
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Adjustment to cancer is a process of transition as individuals attempt to integrate and 
leam from the changes precipitated by their illness (Brennan, 2001). The social-cognitive 
transition model of adjustment (SCT) (Brenn an, 2001) is a normative model of 
adjustment that integrates the paradox of contradictory outcomes: it accounts for both the 
presence of a high degree of di stress as weIl as the presence of posttraumatic growth. The 
SCT model, drawing upon social-cognitive, coping and traumatic stress theories, posits 
that humans leam from cumulative experiences throughout their lives and develop an . 
assumptive world composed of abstract schematic representations of themselves, the 
social and physical world (Brennan, 2001; J anoff-Bulman, 1992). These assumptions 
allow individuals to make sorne predictions about their environment and also provide a 
motivational structure for a person's life. When presented with new information 
individuals will either assimilate the information in their existing assumptions 
(strengthening of assumptions) or modify their existing assumptions in order to 
accommodate the new information (elaboration or expansion of assumptions) (Brennan, 
2001; Piaget, 1952). While early manifestations of PTSD symptoms are common 
following traumatic events, the development of the full syndrome is only present in a 
minority of individuals (Brennan, 2001; Kessler, 2000; Tedeschi & Calhoun, 2004). 
People may respond differently in the face oftraumatic events based on their differing 
models of the world and their different social conditions and their sociodemographic 
characteristics. A flexible assumptive world allows for a graduaI integration of novel 
information, while individuals who hold inflexible models and who suppress mismatched 
information may be more vulnerable to develop long-lasting PTSD symptoms. 
When faced with a life-threatening diagnosis such as cancer, the capacity of the 
assumptive world to process the information, to make predictions and to react adaptively 
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may be overwhelmed. In our study, the cancer diagnosis was a shock for many of the 
participants, a finding that matches what has been reported in the literature (Brodsky, 
1999, Dunkel-Schetter, Feinstein, Taylor, & Falke; 1992). Survivors recalled a sense of 
helplessness and fear following diagnosis, their appraisal matching the definition of a 
traumatic stressor. A study has found that the severity of the disease (indicated by disease 
stage and number oftreatments received) was not related to appraisals ofbreast cancer 
meeting the stressor criteria for PTSD (Cordova et al., 2001 ),evidence that individual 
appraisals of the situation are in fact more important than the severity of the event itself. 
In this study, survivors reported a strong sense of fear and uncertainty about the future as 
weIl as a fear of death. Sorne had sorne anxious thoughts, anticipated the future with 
worry and many reported a state of denial after diagnosis. However, for sorne, the 
diagnosis was quickly reappraised as a challenge as patients were reassured by 
physicians. Early positive reappraisal of the trauma may be a factor that leads to a timely 
retum to homeostasis following a cancer diagnosis. Positive appraisals and reappraisals 
of a traumatic event may protect against developing PTSD (Olff, Langeland, Draijer, & 
Gersons, 2007). Positive reappraisals have been linked to faster cortisol habituation to 
subsequent stressors, indicating agreater flexibility in the system (Epel, McEwen, & 
Ickovics, 1998). 
A voidance and denial may be part of the normal adaptive process that preserves a 
coherent mental model of the world, while defending against threatening and painful 
information that cannot be easily integrated into the assumptive world (Brennan, 2001;. 
Horowitz, 1986). Immediately after the diagnosis, patients reported denial, avoidance and 
a blunted emotional reaction. These reactions may serve as a protective function and may 
or may not be reflective of underlying distress. At the time of diagnosis, the many 
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implications of cancer need to be absorbed. In the initial period following diagnosls, 
avoidance adaptively protects the individual from the overwhelming nature ofthis 
stressful experience. However, the competing psychological need to assimilate the new 
information into the existing assumptive world may lead to manifestations of intrusions, 
rumination and reexperiencing. Consequently, co-existing manifestations of avoidance 
and intrusions are opposed parts of the regulation of information absorption (a process 
particularly notable in the long-term survivorship phase ofthis study). In t~is study, the 
intrusive thoughts reported at diagnosis and treatment strongly resembled anxious worries 
about the future threats while intrusions reflecting past experience only appeared post-
treatment. The results presented in this study illustrate the many anxious worries about 
the future that patients experience: the fear of death, the unknown nature oftreatments, 
possible complications and side-effects. These anxious worries resemble the intrusive 
symptoms ofPTSD, but they are related to preparing oneselfto respond to a future threat 
rather than the recurrent thoughts about a past trauma as is more typical ofPTSD. As 
mentioned elsewhere (Mundy & Baum, 2004), the worries in patients diagnosed with a 
life-threatening illness may be more future-oriented than focused on the pasto In our study 
it is only in the long-term survival phase that intrusions made their appearance, earlier 
observations may be more characteristic of anxiety. 
When patients were receiving chemotherapy treatments, depressed mood was 
increasingly reported and with greater intensity. This was the only time when patients felt 
despair with a sense of discouragement, which was at times accompanied by thoughts of 
death. Being unable to enjoy usual activities like others, the demanding treatments, 
boredom, nausea and fatigue were precipitating factors for depressed mood and anger. 
. This period of emotional turmoil and intensive hardship may force individuals to revisit 
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long-held assumptions. SpecificaIly, life trajectory and life goals may be threatened as 
patients start to envi sion their death and are also faced with physical limitations. Life as a 
cancer patient revolves around treatment rituals and there is a possibility that the patients 
develop maladaptive assumptions about their life-trajectory such as feelings of despair 
and a sense of foreshortened future. In our study, sorne survivors mentioned how their 
existing assumptions about the rational and moral nature oftheir lives were challenged. 
Assumptions about the self and self-worth, and the sense of control over the world are 
also challenged during the treatment period. Body-image issues, loss of masculinity and 
loss of self-esteem were themes mentioned by participants which replicates earlier 
findings (Green, Galvin, & Home, 2003); also the potential for infertility in the aftermath 
of cancer may force individuals to revisit important assumptions and life goals (Robitaille 
et al., under revision). 
In the post-treatment phase, many survivors reported a generally good adjustment and 
posttraumatic growth. However, this period was by no means devoid of distress, more 
survivors reported the presence ofPTSD symptoms, such as high intrusions, avoidance, 
hypervigilance and emotional numbing. It has been suggested elsewhere that trauma 
occurs following the cancer experience because during treatment aIl the energy is 
centered on healing (Brodsky, 1995). In the post-treatment period, avoidance was salient 
for many patients, as weIl as other signs of distress. There is a potential for maladaptive 
assumptions to emerge, enduring di stress and wh en symptoms persist they become 
problematic for survivors. In our study, sorne participants experienced problematic 
alcohol and drug use, and sorne mentioned a delayed emotional reaction. The end of 
treatment phase is described as difficult as survivors experienced a loss of support and 
loss of special attention from medical staff and social networks. The reality of life after 
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cancer may be distinct from that ofbefore the cancer. The uncertainty about a possible 
r" recurrence may prompt hypervigilance and lead to an increase in intrusive symptoms. 
The fear of recurrence contributes to maintaining the perception of a sense of current 
threat post cancer treatments and encourages a beliefthat the trauma is not time-limited 
as discussed by the cognitive model of Ehlers and Clark (2000). Fear of recurrence has 
been shown to be positively related to PTSD symptoms in a sample oflymphatic cancer 
survivors (Black & .White, 2005). 
While assumptions are being shattered, they may also be replaced by other adaptive 
schemas, which produce posttraumatic growth. For growth to take place, the trauma has 
to be challenging enough to put into question the way that the pers on understands the 
world and this implies a change in this understanding. Thus, there is a large potential for 
growth as the person integrates the new reality of trauma in the assumptive world through 
the inclusion of new assumptions and the exclusions of old ones. Nonetheless, the 
relation between distress and posttraumatic growth is tenuous. The di stress and pain 
triggered from the traumatic event are not seen as positive outcomes and the crisis is not 
itself seen as desirable even in the event of posttraumatic growth. It is important to 
recognize that posttraumatic growth and di stress are not mutually exclusive and often co-
occur, and one may not be a necessary condition for the other. In a sample of breast 
cancer patients, Cordova (2001) found that posttraumatic growth scores were not related 
to scores ofPTSD or depression, nor was posttraumatic growth related to greater well-
being. 
The coping processes taking place also influence the cognitive integration of trauma 
and the extent of posttraumatic growth. For example, the opportunity to talk about the 
experience of cancer and the presence of social support may be beneficial to cognitive 
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processing and may help through the provision of altemate schemas (Tedeschi & 
Calhoun, 2004). In contrast, individuals who are remarkable in hardiness possess a high 
sense of coherence and who are highly resilient, may not be challenged sufficiently by 
the traumatic event to enter a process of revaluation of existing schemas (Tedeschi & 
Calhoun, 2004). In our study, sorne survivors mentioned coping by staying active, which 
might reflect an attempt to preserve assumptions about the self. In contrast, personality 
characteristics such as optimism, extraversion and openness to experiences, which allows 
for a flexible re-evaluation of assumptions, may make posttraumatic growth more likely 
(Tedeschi & Calhoun, 2004). In two distinct prospective studies ofbreast cancer patient 
investigators found that optimism as measured in the initial interview was inversely and 
strongly related to distress at each time point (Carver et al., 1993; Epping-Jordan et al., 
1999). Coping by optimism may take place mostly at the beginning and through 
treatments and ifthere is a chronology ofposttraumatic growth. It does not seem to occur 
straight after the event, but rather as lesson leamed from the experience and whether it 
endures many years post-completion oftreatments is an issue that remains to be 
investigated. 
Limitations 
The results of this qualitative study may not generalize to other cancer populations of 
young males, to female cancer patients, or to older patients. In addition, the use of a 
convenience sample may have biased results by attracting participants who were most 
interested or who had more symptoms. Generalizations are also restricted by the large 
amount oftimeelapsed between the diagnosis ançl data collection (6.3 years) which may 
have lead to a bias in recall about psychological reactions at that time. Future research on 
the presence of the sub-syndromal and the full-syndrome ofPTSD is needed through 
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longitudinal and prospective quantitative studies. These studies could identify sub-groups 
of patients who are more at risk of developing pathological responses and inform health 
care professionals conceming the rnanner to direct lirnited resources towards helping 
these patients. As other authors have noted, the relationship between distress and 
posttraurnatic growth is unc1ear (Tedeschi & Calhoun, 2004); it rnay be associated with 
less di stress in sorne studies or show no apparent relation to one another. This association 
needs to be c1arified. 
Conclusions 
In the initial stage following the diagnosis, survivors are living a period of intense 
shock and distress. They also report that the rnedical joumey ahead of thern is frightening 
and report sorne experience of anxiety. A voidance and denial are cornrnon initial 
reactions. It would be appropriate to recornrnend that the large arnount of information 
presented to patients be repeated several tirnes by the rnany professionals that encounter 
each patient. Several repetitions rnay alleviate sorne of the stress associated with the 
unfarniliar process~s that will order their lives for the rnonths ahead; when the initial 
diagnosis is reappraised as sornething rnanageable; a challenge over which one can 
exercise sorne control, and therefore patients rnay be less likely to experience PTSD 
symptorns. The results of our study suggest that patients are under a significant arnount of 
ernotional duress especially during the treatrnent phase. Patient's initial concems often 
carry over through the treatrnents and post-treatrnent phase. Furthermore, additional 
support (social, ernotional and practical) is important at the end oftreatrnent, where new 
psychological challenges rnay appear. Clinical interventions rnight be an important 
source of support for patients in this stage. 
/ 
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Table 
Table 1 
Summary of PTS D, distress, coping and PTG: transitions through the cancer experience 
Diagnosis phase Treatment phase 
Appraisals 
• Shock very common 
• Fear of death, foreshortened future 
• Helplessness and horror 
• Quickly reassured about a good prognosis 
by the health care professional: threat being 
reappraised as a challenge 
• Existential questioning 
PTSD Symptoms: 
• Anxious anticipation: intrusive thoughts 
rare 
• Fear about the future and the unknown 
pro cess of cancer treatments 
• DeniaI (unconscious-related to shock) 
• Avoidance 
• Numbing 
• Depersonalization 
• Nightmares 
Distress: 
Anxiety : apprehensions about the future 
Depressed M ood 
• sadness 
Appraisals 
• Shock receding, less frequent, present in 
one individual 
• Fear of the future, treatments 
• Cognitive processing of cancer experience 
beginnings 
PTSD Symptoms: 
• Anxious anticipation: intrusive thoughts 
rare 
• Fear about the future and the unknown 
pro cess of cancer treatments ' 
• A voidance becoming more frequent 
• DeniaI 
• Nightmares 
• Hypervigilance 
Distress: 
Anxiety important in a wide-range of areas 
concerning treatment 
Depressed Mood 
• SuicidaI thoughts /thoughts of death 
• Despair 
Other di stress symptoms reported through ail phases: 
68 
Long-term survival 
Appraisals 
• Delayed emotional reaction 
• Cognitive processing of the cancer 
experience 
• Fear of recu rren ce 
• Loss of medical support and attention: fear 
of recurrence: appraisals of the trauma that 
maintain a sense of current threat need to be 
modified. 
PTSD Symptoms: 
• Intrusive thoughts most frequent in this 
phase' 
• Fear about recurrence 
• Fear of secondary impact on their lives 
• Avoidance most frequent in this phase 
• Numbing 
• Hypervigilance 
• Trouble remembering important parts of the 
experience 
• Sense of foreshortened future 
Distress: 
Anxiety important in a wide range of areas 
concerning survivaL ' 
Depressed M ood 
Drug abuse/self-destructive behavior 
change in body image, loss of self-esteem, anger, fatigue, boredom, anticipatory nausea, worries about the possibility of infertility, being cut offfrom 
regular activities 
Coping 
• Optimism 
• Early acceptance 
• Confident, focusing on future plans 
• Maintaining a regular activity level 
• Seeking social support-emotional support 
• Keeping a strong front 
Posttraumatic growth 
Not yet in effect 
Coping 
• Optimism 
• Acceptance 
• Maintaining a regular activity level 
• Seeking social support-emotional support 
• Active information seeking 
• Humor 
• Comparison to others 
• Consulting a professional 
• Keeping a strong front 
Posttraumatic growth 
• Closer bonds with family and friends; 
reevaluating social ties 
Coping 
• 
• 
• 
• 
• 
• 
• 
Late acceptance 
Optimism 
Seeking social support-emotional support 
Humor 
Comparison to others 
Consulting a professional 
Keeping a strong front 
Posttraumatic growth 
General good adaptation, feelings of having 
moved on from the experience 
• Change in identity for the better (feeling 
more mature, more sensitive, a stronger 
person, more compassionate) 
• More appreciation of life 
• Taking more time for one self 
• Revaluation ofpriorities in life (less stress 
for trivial things, 
• Closer bonds with family and friends 
L. .. 
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Abstract 
Testicular and Iymphatic cancers (Hodgkin's and non-Hodgkin's disease) are among the 
most common cancers in young males aged 18 to 45. It has recently been acknowledged 
that symptoms ofposttraumatic stress disorder (PTSD) may be present following a cancer 
diagnosis, with incidence varying between 1.9% to 35.1 % (Kangas, Henry & Bryant, 
2002). Few studies have investigated the emergence ofthese symptoms longitudinally in 
the first year following diagnosis. This study investigates early manifestations of PTSD 
symptoms, the course of symptoms over 12 months and their predictors in a sample of 
patients with cancer as compared to a group of healthy controls. Methods: Newly 
diagnosed cancer patients (n=92), and community controls (n=88) were recruited. ( 
Participants were assessed on measures of PTS D, depression, anxiety, perceived stress 
and quality oflife at diagnosis, 3 months, 6 months, and 12 months post-diagnosis. 
Results: Severe PTSD symptoms were observed in 3.4% to 8.3% of cancer patients on 
the PTSD Checklist-Civilian Version (PCL-C) and in 7% to 14.3% on the Impact of 
Event Scale (lES) over the four assessment points in the first year following diagnosis, 
compared with 1.5% to 3.9% on the PCL-C and 1.3% to 5.7% on the lES for controls. 
Repeated measure analyses of variance (ANOV As) revealed that cancer patients had 
higher levels of PTSD symptoms, at time 2 and 4 on the lES, at times 2, 3 and 4 on the 
PCL-C, at time 2 for depression, and at times 1 and 2 for anxiety than control s, but were 
not different in perceived stress, nor in quality of life. Furthermore, there was a 
significant increase in PTSD symptoms over time. Initial scores ofPTSD were the only 
significant predictor of PTSD at time 4. Conclusion: This study pointed to the 
pervasiveness of early PTSD symptoms and revealed an increase in PTSD symptoms for 
cancer patient between 6 and 12 months. 
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Introduction 
In persons diagnosed with cancer, 35% to 45% of patients suffer from elevated 
levels of di stress at sorne point during their cancer trajectory that may require 
intervention (Zabora, BrintzenhofeSzoc, Curbow, Hooker, &Piantadosi, 2001). Given 
that posttraumatic stress disorder (PTSD) is highly comorbid with depression, anxiety 
and other types of di stress (Amir & Ramati, 2002; Deimling, Kahana, Bowman, & 
Schaefer, 2002; Edgar, Rosberger, & Nowlis, 1992; Epping-Jordan et al., 1999, Haber et 
al., 2002; Kessler, Borges, & Walters, 1999) symptoms ofthis disorder are likely to be 
elevated in young males with cancer. 
The objectives ofthis study are to determine the frequency of cancer-related PTSD 
symptoms in young male cancer patients, to understand how symptoms of cancer-related 
PTSD evolved in the first year following cancer diagnosis and to identify risk factors 
which are predictive of PTSD symptoms 
For trauma most stressors are acute. The nature of a cancer diagnosis as a 
traumatic event involves both acute and chronic stressors (diagnosis, surgery, repeated 
chemotherapy and/or radiation therapy, side-effects, delayed effects, follow-ups, risk of 
recurrence and the long-term survivorship period). Since the recognition by DSM-IV 
(American Psychiatric Association [APA], 1994) that life-threatening illnesses, such as 
, cancer, could be of sufficient magnitude to meet the criteria of a traumatic stressor, a 
number of investigations of PTSD symptoms in cancer patients have been conducted 
(Andrykowski, Cordova, Studts, & Miller, 1998; Epping-Jordan et al., 1999; Kangas, 
Henry & Bryant, 2002; 2005a). This literature' indicates that cancer is often experienced 
by patients with shock, fear and helplessness (Brodsky, 1999; Robitaille, Rosberger, & 
Achille, 2008 under review). However, most prior studies of PTSD outcomes in cancer 
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patients or survivors have relied on cross-sectional designs (Andrykowski et al., 1998; 
Butler, Koopman, Classen, & Spiegel, 1999; Cella & Tross, 1986; Cordova, 
Cunningham, Carlson, & Andrykowski, 2001; Fleer et al., in press; Kaasa et al., 1993; 
Komblith et al., 1992; Palmer, Kagee, Coyne, & DeMichele, 2004) and none have 
compared the outcomes of patients to a control group, despite the fact that lifetime 
exposure to a qualifying traumatic event in the general population has been assessed to be 
within the range of 40% to 89 % in epidemiological studies (Breslau, Davis, & Petersen, 
1991; Green, 1994; Kessler, Sonnega, Bromet, Hughes, & Nelson, 1995; Norris, 1992). 
Furthermore, few have 'explored the course of development of PTSD symptoms 
longitudinally. In a series ofpapers drawn from a single prospective study (Kangas et al., 
2005a; 2005b; 2005c; 2005d), there was significant dec1ine in PTSD symptoms from 
diagnosis to 1 year post-diagnosis, and none ofthose that had low acute stress disorder2 
scores at diagnosis developed PTSD at 1 year, pointing to the importance of an early 
assessment ofPTSD symptoms following cancer diagnosis. However, this study used a 
mixed cancer sample (head and neck cancer and lung cancer) and also showed that there 
were significantly more women (47% and 42%) than men (13% and 5%) who met the 
criteria for a PTSD diagnosis at 6 and 12 months (Kangas et al., 2005a, 2005b). Other 
prospective studies pointed to a dec1ine in PTSD symptoms in general (Manuel, Roth, 
Keefe, & Brantley, 1987) or in intrusions (i.e.: cognitive and affective reexperiencing of 
the traumatic event) but not in avoidance (i.e.: avoidance oftrauma-related reminders and 
feelings) after diagnosis (Epping-Jordan et al., 1999). The few studies described above 
have used mixed gender samples or female-only samples; none have investigated PTSD 
2 Acute Stress Disorder is a diagnosis that applies to individu aIs having been exposed to a traumatic event 
and who exhibit symptoms for a period of two days to four weeks following the event. A PTSD diagnosis 
cannot be given to patients until the y have exhibited symptoms of the disorder for at least 1 month. 
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longitudinally in males. The higher risk of PTSD in women is one of the most consistent 
findings in the epidemiology of posttraum~tic stress disorder (Olff, Langeland, Draijer & 
Gersons, 2007). Women are twice as likely as men to develop PTSD in their lifetimes 
(10.4% vs 5%) even though men are more likely to be exposed to traumatic events in 
their lifetime (Kessler et al., 1995). PTSD symptoms following cancer have been 
measured in older women (mostly breast cancer patients) but not in younger men. 
Testicular cancer and lymphatic cancers are among the most cornillon types of 
malignancies in men aged 45 or younger (Canadian Cancer StatisticslNational Cancer 
Institute of Canada [CCSINCIC], 2002; Trask, Paterson, Fardig, & Smith, 2003). Hence, 
the diagnosis cornes at a time wh en males are concemed with finishing their studies, 
focusing on their careers, getting married and building a family, but when it is generally 
unexpected developmentally to be facing cancer. 
There are no reports about the early development of PTSD symptoms and distress 
for young testicular and lymphatic cancer patients, or about the evolution of these 
symptoms during the first year following diagnosis. Low incidence rates of these 
diagnoses are a challenge to longitudinal studies. The National Cancer Institute of 
Canada (CCSINCIC, 2008) estimates that there will be 890 new cases of testis cancer in 
2008,3800 new cases ofNon-Hodgkin's lymphoma and 480 new cases ofHodgkin's 
lyillphoma in males of aIl ages. Incidence rates are low, but have been steadily increasing 
in recent years. These disorders reach a peak incidence for males between the ages of 18 
to 40, share comparable chemotherapy regimens (side-effect profiles, chemotherapy 
drugs used, potential for infertility post-chemotherapy), and aIl three have relatively good 
prognoses (Fossa & Dahl, 2002; Kaasa, Aass, Mastekaasa, Lund, & Fossa, 1991; 
Raemarkers et al., 2002, CCSINCIC, 2008). 
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In general, younger age, past traumatic exposure, and prolonged or inescapable 
traumatic events constitute risk factors for PTSD (Herman, 1992). Lower age is related to 
increased symptoms of intrusions (i.e.: persistent and uncontrollable thoughts about the 
event, tecurrent dreams about the event, physiological and emotional arousal upon cues 
resembling the event) and avoidance (efforts to avoid thoughts, feelings, conversations, 
places, and activities associated with the event, incapacity to recall important aspects of 
thé event) in long-term breast cancer survivors (Butler et al., 1999) as well as newly 
diagnosed breast cancer patients (Epping-Jordan et al., 1999). Other variables such as 
lower education (Cordova, Andrykowski, Kenady, McGrath, Sloan, & Redd, 1995; 
Epping-Jordan et al., 1999) and lower income (Cordova et al., 1995) are also associated 
with an increased presence of PTSD symptoms in breast cancer patients. Key studies to 
date have failed to demonstrate significant relation between medical variables, such as 
disease stage or total number oftreatments received and subsequent PTSD (Cordova et 
al., 2001; Kangas et al., 2005a, 2005b). 
Rationale 
The present study is the first longitudinal study of cancer-related PTSD symptoms 
to compare outcomes in young male cancer patients with that of a healthy control group. 
This study aims to identify the frequency, risk factors, and evolution of the PTSD 
symptoms. Psychological morbidity will be assessed to gain an understanding of the 
relationship between PTSD, depression and anxiety in these patients. 
Hypotheses 
It is hypothesized that: a) incidence rates of PTSD symptoms will be higher in 
cancer patients than in the control group, b) initial levels of PTSD symptoms will highly 
predict subsequent levels ofPTSD symptoms, c) the highest level ofPTSD symptoms in 
75 
patients will be at the time of diagnosis and will steadily decrease over time, d) younger 
age, prior history of trauma, lower education level and lower socioeconomic status will 
increase the likelihood ofPTSD symptoms, and e) PTSD will be highly correlated with 
depression and anxiety. 
Methods 
Participants 
Two groups of subjects were recruited: cancer patients (newly diagnosed with 
testicular, Hodgkin's, or non Hodgkin's lymphatic cancer) and healthy contraIs (healthy 
community volunteers and patients recruited at a fertility clinic). Ethics appraval was 
obtained by the McGill University Institutional Review Board prior to the beginning of 
the study. Recruitment of newly diagnosed patients took place in hospitals in the 
Montreal are a (Royal Victoria Hospital, Charles-Lemoyne Hospital, Jewish General 
Hospital-SMBD, Montreal General Hospital). Patients received written information about 
the study from their doctor, and those who expressed interest were contacted by the 
research coordinator prior to the initiation of chemotherapy treatments. Inclusion criteria 
for the patient sample of the study included : a) being between 18 and 45 years of age; b) 
having a sufficient physical and psychological health status to answer the questionnaires; 
c) receiving chemotherapy for the first time; d) having no history of a previous malignant 
tumor; e) having no history ofradiotherapy. The healthy controls and infertile but 
otherwise healthy aged-matched controls (who had no history of cancer) were recruited 
through advertisement in local newspapers, and in a fertility clinic in Montreal. 
Study design and procedures 
Participants completed questionnaires and were interviewed at the following time 
points: time 1: just after diagnosis (and prior to the initiation of chemotherapy); time 2: 3 
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months post-diagnosis; time 3: 6 months post-diagnosis; time 4: 1 year post-diagnosis. 
Participants answered questionnaires in the presence of a trained interviewer available to 
answer questions at aIl time points except for time 2. Time 2 is a measurement time that 
was added to the original protocol and started sorne months after the beginning of 
recruitment; hence sorne of the first participants did not receive time 2. At time 2 patients 
were contacted by telephone because it was the only time point that did not coincide with 
regular medical foIlow-ups. Telephone surveys using standardized scales have been used 
to assess mental health in primary care research and they have proven to be a co st-
effective mode of data gathering. There is a generally good agreement between data 
gathered by face-to-face interviews and that gathered by telephone interviews (Evans, 
Kessler, Lewis, Peters, & Sharp, 2004), and they have been found to be a valid method 
for measuring PTSD (Andrykowski et al., 1998). Sociodemographic data regarding age, 
income, education, marital status, employment status and number of children was 
collected at time 1. 
Measures 
Posttraumatic Stress Disorder. The Impact of Events Scale (lES) is a 15-item self-report 
questionnaire measuring the presence of intrusions (7 items) (i.e.: cognitive and affective 
reexperiencing of the traumatic event) and avoidance (8 items) (i.e.: avoidance of trauma-
related memories and feelings) over the past 7 days. Separate scores may be calculated 
for these two'scales, and they may be summed for a total score. Norms for both the total 
score and the separate subscales have been published for other cancer populations and 
may be used for comparison. Scores range from 0 to 35 for the intrusion subscale, 0 to 
40 for the avoidance subscale and 0 to 75 for the total lES. Although the lES is not a 
diagnostic tool, the lES total score has been used to define three levels of clinical 
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concern: a score below 9 as "low", 9 to 19 as "rnoderate", and over 19 as "high" 
(Horowitz, 1982; Johansen, Wahl, Eilertsen, Hanestad, & Weisaeth, 2006). However, 
recent studies have ernployed more stringent criteria in scoring the lES. A total lES score 
of 26 and above was the established PTSD caseness criterion ernployed in the present 
study and prior investigations (Corneil, 1995; Fleer et al., in press; Murphy, Randal, Pike, 
& Johnson, 1999; Violanti, Andrew, Burchfiel, Dom, Hartley, & Miller, 2006). The 
scoring criteria ernployed by the present study is: below 9 as the absence of symptorns, 9-
25 as a rnild presence of symptorns, 26-43 rnoderate level of symptorns (warranting 
clinical concern, possible need for treatrnent, likely PTSD) and scores of 44 and above as 
a severe presence of symptorns (Violanti et al., 2006). The lES has a good convergent 
validity with the Clinician adrninistered PTSD Scale (CAPS). It correlations r=O.81 
p<O.OOl with the endorsed symptorns on the CAPS and r=O. 78 p<O.OOl with the CAPS 
intensity score (Neal, Busuttil, Rollins, Herepath, Strike & Turnbull, 1994). Using a cut-
off score of 35, the lES showed a sensitivity of 0.89, a specificity of .88, and a positive 
predictive value of .88 with the CAPS (Neal et al., 1994). The lES produced a 
rnisclassification error rate of 11.4% (Neal et al., 1994). 
In this study, the scale showed high internaI consistency as indicated by Cronbach 
alphas between .91 and .92 for the total scale, between .87 and .89 for the intrusion 
subscale, and between .83 and .85 for the avoidance subscale. The lES has lirnited 
content validity for PTSD as it does not assess symptorns ofhyperarousal (criterion D), 
do es not coyer sorne avoidant symptorns and sorne intrusive symptorns (Joseph, 2000). It 
rernains one of the rnost widely used self-report rneasures oftraurnatic stress (Joseph, 
2000), but another rneasure of PTSD symptorns was also included in the study which 
palliates to sorne of the lES weaknesses. 
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The PTSD Checklist- Civilian (PCL-C) has good face validity and content validity as 
it assesses the presence of 17 symptoms each corresponding to the specifie symptoms of 
PTSD according to the DSM-IV (APA, 1994). It measures intrusions, avoidance, 
hypervigilance and numbing in the past month. The scoring used was the eut-off method: 
a score of 50 and above constitutes a clinical PTSD level, a score of 40 and above 
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constitutes a partial PTSD (Andrykowski et al., 1998; Ruggerio, Del Ben, Scotti, & 
Rabalais, 2003). The PCL-C has good convergent validity with the Structured Clinical 
Interview for DSM-V- PTSD (SCID-PTSD) (Andrykowsky et al. 1998). Using a eut-off 
score of 50 and above, the PCL-C showed a sensitivity of 0.60 (with two false negatives; 
making it more likely that people with the disorder were not identified), a specificity of 
0.99, a positive predictive power of 0.75 and a negative predictive power of 0.97. The 
"--diagnostic efficacy ofthe PCL-C in that study was 0.96 (Andrykowsky et al. 1998). In 
the current study, the scale showed high internaI consistency as indicated by Cranbach 
alphas between .91 and .94 for the total scale. Both the lES and PCL-C are frequently 
used in studies of canceraus populations (Andrykowski et al., 1998; Butler et al., 1999; 
Cordova et al., 1995; Epping-Jordan et al., 1999), and have demonstrated uniformly high 
internaI consistency. Patients answered the questionnaires measuring posttraumatic 
reactions by referring to their cancer experience, infertile contraIs referred to their 
experience of infertility and the healthy contraIs were asked to refer to their most 
stressfullife event and to indicate the date at which the event occurred. 
Distress. The Symptom Checklist-90 (SCL-90) was used to measure distress, specifically 
depression and anxiety. The instrument is composed of 9 subscales and allows for the 
calculation of a total general seventy index (Deragatis, 1977, 1994; Deragatis & Savitz, 
1999). Total scores are transformed into t-scores based on a normative sample of males, 
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according to the gui deI in es provided in the scoring manual of the instrument (Derogatis, 
1994). InternaI consistency was high in the present study with Cronbach alpha's varying 
between .97 to .98 for the total scale, from .86 to .93 for the depression subscale and from 
.83 to .89 for the anxiety subscale. This scale has also been previously used in samples of 
cancer patients (Amir & Ramati, 2002; Epping-Jordan et al., 1999). 
Perceived Stress. The Perceived Stress Scale (PSS) was used to assess perceived stress. It 
is a 14-item scale designed to measure the degrees by which situations in one's life are 
appraised as stressful (Cohen, Kamarck, & Mermelstein, 1983). Items were designed to 
tap how unpredictable, uncontrollable, and overloaded respondents find their lives. The 
scale also inc1udes a number of direct queries about CUITent levels of experienced stress. 
Moreover, the questions are of a general nature and hence are relatively free of content 
specific to any sub-population group. The, questions in the PSS ask about feelings and 
thoughts during the last month (i.e.: ln the last month, how often have you been upset 
because of something that happened unexpectedly?). In the present study, internaI 
consistency varied from .80 to .86. 
Quality of fife. The Functional Assessment of Cancer Therapy-General (F ACT -G) is a 
scale that measures health-related quality oflife along four subscales dimensions: 
physical, social and familial, emotional and functional well-being (Cella et al., 1993). 
The scale contains 27 items for cancer patients and 21 items for the general population 
because 6 items address issues specific to illness (Brucker, Yost, Cashy, Webster, & 
Cella, 2005). Subscales are prorated according to the number of items answered and the 
number of items on the scale [(Sum ofitem score) x (N of items on the scale)]/N of item 
answered. The scale showed high internaI consistency with Cronbach alphas ranging 
from .86 to .91. 
80 
History of trauma. Because a prior history oftrauma may constitute a risk factor for the 
development ofPTSD at an ulterior moment it is important to control for its presence. 
Trauma history was assessed at time 1 with a question derived from criterion A 1 for 
PTSD of the DSM-IV (APA, 1994) (hereafter referred to as trauma history). The item 
read: 
Have you ever lived. been witness. or have been confronted to a stressful event 
where you could have been seriously injured. threatened of death or where there 
was danger for your physical integrity or that of another? (The event you 
lived/witnessed is? The date of this event is?) 
The decisional criterion was that ofbeing an event that could expose the participant to 
potential death or physical harm (see appendix 1 for a complete list ofreported events 
coded as traumatic vs. non-traumatic). This variable was dichotomized and scored as 
present or absent. 
Stressfullife events. The Social Readjustment Rating Scale (SRRS) (Holmes & Rahe, 
1967; Scully, Tosi, & Banning, 2000) is the most often used measure of stressful life 
events. The SRRS consists of 43 life events, commonly reported as stressful identified 
from clinical psychological experiences (Ho lm es & Rahe, 1967). These items share the 
similarity ofbeing events that require a certain level of ad just me nt from one steady state 
to another, regardless of the desirability of the event. Nonetheless, items respect the logic 
that uncontrollable and undesired event will generate a greater stress response than 
controllable and desired event (Scully et al., 2000). Items include events about family, 
marriage, occupation, finances, residence, social relations, education, religion, recreation 
and health (Holmes & Rahe, 1967). The original scale represented a range of typical life 
events classified from most to least stressful in terms ofwhat was historically appropriate 
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in the late 60s. This study employed the revised scale (with items differently weighed and 
formulated) proposed by Scully and Tosi (2000) and measured stressful life-events in the 
past year at time 4. Higher scores indicate more probability of stress related illness 
(Holmes & Rahe, 1967). 
Findings 
Sample Characteristics 
The final sample consisted of 180 subjects. The cancer group consisted of 48 testicular 
cancer, 29 Hodgkin's Lymphoma, and 15 non-Hodgkin's Lymphoma patients (total n = 
92). Because prognosis, age group, treatments received and side-effects in these patients 
with cancer are very similar (CCSINCIC, 2008) we decided to combine the groups to 
increase statistical power (Cohen, 1969, 1992). Independent sample t-tests were 
conducted to test the mean differences between testicular, Hodgkin's and non-Hodgkin's 
cancer patient on key measures (depression, anxiety,'intrusions, total lES, PCL, age). No 
differences were found between groups on any oftheses measures except for the 
avoidance subscale of the lES where the NHD group had higher avoidance than the HD 
t(42) = -2.07 p<0.05 at time 1 and than the TC t(61) = -2.42 p<0.02 at time 1, but not at 
any other time points. The control group consisted of 64 community controls and 24 
infertile controls (total n=88). Comparisons were performed to test the mean differences 
between the community controls and infertile controls on key measures (depression, 
anxiety, intrusions, avoidance, total lES, PCL, age). No differences were found between 
the. two groups on any of the measure, except for age t(88)= -7.1 p<O.OOO 
(infertile controls being slightly older), at any of the time points. Another conceptual 
justification for the combination of the control groups is that the purpose of this study is 
to clarify how young men diagnosed with cancer experience symptoms ofPTSD 
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cornpared to young men frorn the general cornrnunity. The need for a sufficient statistical 
power in analyses (Cohen, 1969, 1992) was also a consideration in assernbling the two 
groups in order to avoid false negatives (type II errors: failing to observe a differerice 
wh en in truth there is one). Mean age of the sarnple was 27.1 (SD = 6.67), participants 
were prirnarily single (64.1 %), non-parent (87.8%), had sorne university level education 
(64.1 %) and ernployed full-tirne (44.1 %) (See Table 1 for complete sociodernographic 
characteristics of sarnple). To examine potential differences between groups, 
sociodernographic variables were dichotornized. Marital status was divided into being 
rnarried (or cornrnon law) versus being non-rnarried; incorne was divided. into less versus 
greater than $40 000 per year (rnedian); education was divided into less than versus sorne 
university level education (64.5% of the sarnple had sorne university); parental status was 
divided into parent versus non parent, and ernployment was divided as ernployed (54.7% 
of the sarnple was working full or part-tirne) versus non-ernployed. 
The motives for attrition and the detailed characteristics of those who rnissed a 
tirne point or dropped out before tirne 4 and those who cornpleted aIl tirne points are 
presented in appendix 2. For the control group there was only one substantive difference 
between the drop-outs and those who cornpleted 4 tirne points. Those who rernained in 
the study were less likely to be rnarried than those who rnissed a tirne point or dropped 
out X2 (1, N= 87) = 4.949 p<0.026. For the cancer patients, there was no difference on aIl 
sociodernographic rneasures for those who rernained versus those who-dropped out of the 
study. However, there was a significant difference on the lES scale and subscales. Those 
who dropped out of the study were likely to have higher scores in the lES total [t (90) 
=2.175, p<0.03], and on the intrusion subscale [t (90) =2.193, p<0.03], but not on the 
avoidance subscale [t (90) = 1.692, ns] at tirne 1. 
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T-tests and chi-squares were also conducted between the control and cancer 
groups regarding sociodemographic variables. There ~as no difference between groups 
in terms of marital status and age, but the controls had a slightly higher level of education 
x2 (1, N= 180) =25.75 p<O.OOO (dichotomi~ed as university vs. no university) and the 
cancer group had a slightly higher incomeX2 (l, N= 152) = 5.847 p<0.016 (dichotomized 
as 40000 or less vs. more than 40000), were more likely to be parents X2 (l, N=179) = 
3.308 p<0.069, and were more likely to be employedX (1, N=178) = 3.725 p<0.05 
(dichotomized as working full-time or part-time vs. non employed). 
Preliminary analyses 
The challenge of subject attrition.over time was handled in a number ofways. In 
the longitudinal analyses, missing cases were handled by a pairwise deletion. However, 
even for those who completed each time point, there were occasionally sorne missing 
items on questionnaires (i.e. participant having missed a question on a particular scale). 
When no more than 15% of items were missing on a questionnaire, these items were 
replaced using the maximum-likelihood estimization maximization technique (Enders, 
2003; Little & Rubin, 1989; Peugh & Enders, 2004), in no cases were complete cases 
replaced. 
The longitudinal data was analyzed in two ways. In the first set of analyses, the 
final sample consisted of only the participants who completed every time point. In the 
repeated measure ANOY As only the results representing the final sample are presented. 
The second set of analyses consisted of aIl of the patients available at each particular time 
point (hereafter called the cross-sectional sample). This dual approach to the analytic 
process maximizes the sample size for both the longitudinal and cross-sectional analyses 
and allows for examination of convergence and divergence of the results that may have 
important clinical 'real world' implications. 
PTSD symptoms: descriptive data 
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Of the total sample, 20.1 % of the total sample (18.5% of cancer patients and 
25.8% of the control group) reported having lived through or witnessed an event (in their 
lifetime) that could have caused serious injufy or death to themselves or others (Table 2). 
The mean elapsed time since the event was 80.54 months and the range was 12 to 252 
months (see appendix 1 for a list of reported events). 
To observe levels ofPTSD (none, mild, moderate, severe) symptoms per groups 
at each time point, frequency counts were performed (Table 3). Elevated scores 
'(moderate to severe levels of symptoms) on the lES and PCL-C represent a proxy for 
likely PTSD cases. An examination ofresponse frequencies in the cross-sectional sample 
on the lES revealed moderate to severe levels (score of 26 and above: likely PTSD 
caseness) ofPTSD symptoms in 34.8% of cancer patients at time 1,34.9% at time 2, 
21.2% at time 3 and 24.5% at time 4. For the control groups, 20.5% had moderate to 
severe levels ofPTSD at time 1, 15.6% at time 2, 17.9% at time 3, and 15.1 % at time 4. 
The responses on the PCL-C revealed moderate to severe (score of 40 and above: likely 
PTSD caseness) levels of PTSD symptoms in 13.6% of cancer patients at time 1, 22.2% 
at time 2, 16.6% at time 3 and 20.7% at time 4. For the control groups, 12.5% had 
moderate (subclinical) to severe levels ofPTSD at time 1,3.9% at time 2, 7.5% at time 4 
and 9.1 % at time 4. A complete list of traumatic (or stressful) events reported by control 
participants is available in appendix 3. 
To verify whether initial PTSD caseness (moderate to severe score on the lES 
and PCL-C) had an influence on PTSD caseness at time 4, a series of chi-square analyses 
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were performed between those who had a likely initial PTSD caseness and those who did 
not (as dichotomized between high and low scores). For the final sample chi-squares 
revealed that Il out of37 (29.7%) cancer patients had likely PTSD at time 1 on the lES. 
Of those who had PTSD at time 1, 45.4% also had PTSD at time 2, X 2 (1, N = 37) = 5.25 
p<0.02. Ofthose who had PTSD at time 1,45.4% had PTSD at time 3, X (l, N= 37) = 
7.19 p<0.007; and 72.7% had PTSD at time 4,X2 (1, N= 37) = 16.58 p<O.OOO; while 
Il.5%, 7.7%, and 7.7% ofthose who did not have PTSD at time 1 reached c1inically 
significant levels ofsymptoms at time 2,3 and 4 respectively. On the PCL-C, 5 out of38 
(13.2%) cancer patients had likely PTSD at time 1 on the PCL-C. Ofthose who had 
PTSD at time 1,80% also had PTSD at time 2, X2 (1, N= 38) = 17.85 p< 0.000; 80% had 
PTSD at time 3, X2 (1, N= 38) = 17.85 p< 0.000; and 100% had PTSD at time 4, X2 (1, 
N= 38) = 25.5 p< 0.000; while 6%,6%, and 6% ofthose who did not have PTSD at time 
1 reached c1inically significant levels of symptoms at time 2, 3 and 4 respectively. For the 
final sample of control participants, 14 out of61 (22.9%) had PTSD at time 1 on the lES. 
Ofthose who had PTSD at time 1, 50% had PTSD at time 2 X2 (1, N= 61) = 14.97 p< 
0.000; 64.2% had PTSD at time 3, X2 (1, N= 61) = 26.29 p< 0.000; and 50% at time 4, X2 
(1, N= 61) = 17.95 p< 0.000; while 6.3%, 4.2% and 4.2% ofthose who did not have 
PTSD at time 1 reached clinically significant levels of symptoms at time 2, 3 and 4. On 
the PCL-C, 13.1 % of control participants had PTSD at time 1. Of those who had PTSD at 
time 1,25% also had PTSD at time 2, X2 (1, N= 61) = 7.94 p< 0.005; 25% had PTSD at 
time 3, X2 (1, N= 61) = 7.94 p< 0.005; and 25% at time 4, X2 (1, N= 61) = 3.455 p< 
0.063; while 1.8%, 1.8% and 5.6% ofthose who did not have PTSD at time 1 reached 
c1inically significant levels at time 2, 3 and 4. The lower rates of moderate-to-severe 
PTSD symptoms in the control group are apparent wh en descriptive findings are 
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examined. As was predicted, the cancer patients had significantly greater PTSD symptom 
severity than the controls over time. Repeated measure ANOV As were carried out to 
confirm these observed descriptive group differences. 
Repeated measure ANDV As (Generallinear model) 
Impact of Events Scale 
A repeated measure ANOVA for the total score of the lES scale resulted in significant 
results for the between group (cancer vs. control) effect F(1, 96) =4.46 p<O.04 and the 
group X time interaction F(3, 94) =3.11 p<O.03. The within-group effect oftime was not 
significant.3 Paired sample t-tests (between time 1 and 2, time 2 and 3, and time 3 and 4) 
were performed to examine at which time points significant differences emerged within 
each group and independent sample t-tests (between the cancer and control group at time 
1, 2, 3, and 4) were performed to verify at which time point were the groups significantly 
different. 
Paired sample t-tests for the cancer group revealed a significant difference 
between time 3 and time 4 on the lES total score, where the cancer group experienced a 
3In order to test normality, skewness and kurtosis was verified for aH sc ales at every time point. There were 
violations to the normality assumptions on the lES and PCL-C scales, with most violations being skewed to 
the left (low severity of symptoms), which is to be expected in a non-psychiatrie population. Because of the 
greater facility to interpret and compare findings expressed in the original values of the scale, the original 
non log-transformed data was used in ail analyses. In order to correct for non-normality, naturallog 
transformations were performed on non-normal scales and results from log-transformed data will also be 
presented. Also, it has long been established that moderate violations ofparametric assumptions (i.e. 
normality, homogeneity of variances, and intervallevel ofmeasurement) have little or no effect on 
substantive conclusions in most instances (Cohen, 1969). Because of a concernfor the normality of the 
distribution (on the lES and its subscales and on PCL-C), log transformations were additionally performed. 
Unlike the non-transformed data, the repeated measure ANOVA for the log-transformed lES produced a 
non-significant effect groups X time interaction. However, the within individual effect of time remained 
non-significant, while the between groups effect was still significant F (l, 96) = 1 0.03 p<0.002. In both 
analyses (transformed vs. non-transformed data) there was an overall difference between groups on the lES 
total score. 
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TIse in lES scores t (36) = -2.0 p<0.054 . For the control group on the lES there was a 
significant difference decrease in lES scores from time 1 to time 2 t (60) = 2.586 
p<0.012. Independent sample t-tests revealed that the cancer group had higher scores than 
the controls on the lES at time 2 t (96) = 2.54 p<.013 and at time 4 t (96) = 2.78 p<0.007. 
Mean lES total scores for the final sample at each time point are shown in Figure 1, 
Figure 2 represents the percentage ofindividuals (from the final sample) having elevated 
(moderate and severe levels) symptoms on the lES at every time point. Only the results 
for the final sample are presented in this paper, results for the repeated measure 
ANOVAs for the cross-sectional sample on aIl measures are presented in Appendix 4. 
Intrusion and avoidance subscales of the lES 
The repeated measure ANOVA for the intrusion subscale of the lES yielded a non-
significant effect of group membership. There was a significant groups X time effect, F 
(3,94) =3.58 p<O.01; but there was a marginally significant within-group effect oftime F 
(3,94) =2.56 p<0.06. 5 Paired sample t-tests for the cancer group revealed that there was a 
significant decrease in symptoms on the intrusion subscale of the lES from time 2 to time 
3 t (36) =2.11 p<.042 and a significant increase in symptoms from time 3 to time 4 t (36) 
= -2.58 p<.014. For the control group on the intrusion subscale of the lES, there was a 
significant decrease in symptoms from time 1 to time 2 t (60) = 2.80 p<0.007. 
Independent sample t-tests revealed that the cancer group had higher scores than the 
4 If Bonferroni corrected alphas were used this would become marginally significant (Pemeger, 1998; 
Sankoh, Huque, Dubey, 1997). The significance level would be p<0.025, p<0.0167 and p<0.0125 for 
analyses respectively holding 2, 3 or 4 sets of tests. 
5 The repeated measure ANGV A for the log transformed data on the intrusion subscale of the IES also 
produced very similar results. There was a significant effect for group membership F(l, 96) =8.04 
p<0.006, and a significant effect for both the interaction of groups X time F(3, 94)=2.77, and the within 
individual effect of time F=2.64 (3, 94) p<0.05. 
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controls on the intrusion subscale at time 2 t (96) = 2.57 p<0.012 and time 4 t (96) = 2.25 
p<0.027. 
The repeated measure ANOVA for the avoidance subscale of the lES yielded only a 
significant effect for group membership F (1, 96) =5.08 p<0.03. The within group effect 
oftime and the interaction effect of group X time were not significant. 6 Paired sample t-
tests revealed that for both the cancer and the control group there was no significant 
change through time on the avoidance subscale of the lES. Independent sample t-tests 
revealed that the cancer group had higher scores than the controls on the avoidance 
subscale of the lES at time 2 t (96) = 2.07 p<0.04, time 3 t (96) = 1.9 p<0.06 and time 4 t 
(96) = 2.88 p<0.005. 
PTSD Checklist-Civilian 
The repeated measure ANOVA for the total PCL-C scale demonstrated significant effects 
of group membership F (1, 97) =6.20 p<O.Ol and a significant effect for the interaction of 
groups X time F (3, 95) =3.21 p<0.02. There was no significant effect for the within-
group effect of time. 7 Paired sample t-tests for the cancer group revealed there was a 
significant increase in symptoms on the PCL-C from time 1 to time 2 t (37) = -2.682 
p<O.O Il, but no difference through time for the control group. Independent sample t-tests 
revealed that the cancer group had significantly higher scores than the controls on the 
PCL-C at time 2 t (38) = 6.20 p<0.005, at time 3 t (37) = 5.79 p< 0.007 and at time 4 t 
(38) = 4.62 p<0.037. Figure 3 shows the mean scores for the PCL-C for the final sample 
6 The repeated measure ANOV A for the log transformed data on the avoidance subscale of the lES 
produced the same results. Only the effect of group membership was significant F (3, 94) =7.27 p<0.008, 
and both the within individual effect of time and the interaction effect of groups X time were not significant 
7 The repeated measure ANOV A for the log transformed data on the PCL-C also produced a significant 
effect of group membership F (1, 96) = 8.18 p<0.005 and a significant effect for the interaction of groups X 
time F (3, 94) =5.01 p<0.002. However, with the log transformed data the within individual effect oftime 
became significant F (3, 94) = 3.32 p<0.02. 
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and Figure 4 shows the percentage of individuals (from the final sample) having elevated 
(moderate and severe levels) symptoms on the PCL-C at every time point. 
SCL-90 depression and anxiety 
The repeated measure ANOY A for SCL-90 depression scale revealed a significant effect 
of group membership F (1, 95), =4.67 p<O.03 and a significant interaction of groups X 
time F (3, 93) =3.77 p<O.Ol. There was no significant effect for the within-group effect of 
time. Paired sample t-tests for the cancer group revealed an increase in depression scores 
from time 1 to time 2 t (37) = -2.21 p<O.034 and a significant decrease in symptoms from 
time 2 to time 3 t (37) = 2.45 p<O.OI9, but no significant differences were found for the 
control group. Independent sample t-tests revealed that the cancer group had significantly 
higher scores than the control group on the depression subscale of the SCL-90 at time 2 t 
(95) = 3.97 p<O.OOO. Mean scores are depicted in Figure 5. 
The repeated measure ANOY A for the SCL-90 anxiety scale showed a significant effect 
of group membership F (1,95) =6.34 p<O.OI and marginally significant interaction of 
groups X time F (3, 93) =2.32 p<O.08. There was no significant effect for the within-
group effect of time. Paired sample t-tests revealed that for both the cancer and the 
control group there was no significant change through time on the anxiety subscale of the 
, 
SCL-90. Independent sample t-tests revealed that the cancer group had significantly 
higher scores than the control group on the anxiety subscale of the SCL-90 at time 1 t 
(95) = 2.92 p<O.004 and at time 2 t (95) = 3.392 p<O.OOl. Mean score are depicted in 
Figure 6. 
Perceived Stress Scale 
The repeated measure ANOY A for the PSS scale score produced a different pattern of 
results. In contrast to the PTSD scales, there was no significant effect of group 
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membership on its own. The interaction of groups X time was significant F (2,115) =3.47 
p<0.03. The within-group effect oftime was significant F (2,115) =9.58 p<O.OOO. Paired 
sample t-tests for the cancer group revealed a significant decrease in PSS scores from 
time 1 to time 38 t (54)= 2.588 p<0.012 and a significant decrease for the control group 
from time 1 to time 3 t (62) = 2.44 p<0.018. Independent sample t-tests revealed that the 
cancer group had higher scores than the control group on the PSS at time 1 t (116) = 2.10 
p<0.038. Mean scores are depicted in Figure 7. 
Functional Assessment of Cancer Therapy-General· 
The repeated measure ANOVA for the FACT-quality oflife, the between-group effect 
was not significant. The within-group effect oftime was significant F (2, 115) =3.27 
p<0.04. The interaction of group X time was significant F (2, 115) = 5.24 p<0.007. Paired 
sample t-tests revealed that for both the cancer and the control group there was no 
significant change through time on the F ACT quality of life scale. Independent sample t-
tests revealed that the control group had significantly higher scores than the cancer group 
on the FACT quality oflife scale at time 1 t (116) = -2.47 p<0.015. Mean scores are 
depicted in Figure 8. 
Social Readjustment Rating Scale 
In terms oflife stress as measured by the SRRS, an ANOVA was performed (only a 
single time point was available) there was a statistically significant difference between 
the cancer and control groups. Cancer patients reported higher stress at time 4: 184.78 
(SD=121.93) compared to controls 135.74 (SD=84.19), F (1,101) = 5.836 p<O.017. 
Correlations between independent variables and PTSD 
8 The PSS was not administered at time 2. 
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Table 4 presents the correlation between independent variables and PTSD. For 
sociodernographic variables for cancer patients, point-biserial correlations were 
performed. Marital status was inversely correlated, r = -.22, p<O.05 with anxiety at tirne 
1, incorne was negatively correlated to anxiety at tirne 1, r = -.27, p<O.05 and at tirne 3 . 
(r=-.32). Parental status was negatively correlated to anxiety at tirne 1 r = -.23, p<O.05 
and age was negatively correlated to depression at tirne 4, r = -.28, p<O.05. Level of 
education and ernployment were never correlated to any ofthe outcorne rneasures. None 
of the sociodernographic variables related to any of the outcorne variables for the control 
group. Contrary to what was predicted, none ofthe dernographic variables correlated with 
PTSD rneasures. 
Consistent with initial predictions, correlations between key variables showed strong 
positive associations between both depression and anxiety with both ofthe PTSD scales 
(lES and PCL-C) for both the èancer patients and the controls at aIl tirne points. The PSS 
was also strongly and positively related to depressioTl, anxiety, lES and PCL-C scores, for 
both groups at aIl tirne points. As expected, the F ACT quality of life scale was negatively 
correlated with depression, anxiety, lES and PCL-C scores for both groups at aIl time 
.\ 
points. The SRSS at tirne 4 was related to depression, anxiety, lES and PCL-C at tirne 1, 
to depression and PCL-C at tirne 2, unrelated to aIl rneasures at tirne 3 and related to 
depression at tirne 4 for the cancer groups only. Except for a correlation with the PCL-C 
at tirne 1, the SRSS at tirne 4 was unrelated to aIl rneasures at aIl tirne points for the 
controls (see table 4). Contrary to prediction, history oftraurna was not correlated with 
the lES, the PCL-C, or the SCL-90 depression and anxiety scales for the controls. For the 
cancer patients, the only significant correlation for history oftraurna was with depression 
at tirne 1 (r=.223, p<O.05). 
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Regressions 
In order to test the fourth hypothesis that age, history of trauma, education and income 
would increase the likelihood of PTSD symptoms, these variables were introduced in a 
linear regression to predict PTSD at time 4. While correlations already indicated non-
existent to low relations between these variables sociodemographic variables and PTSD, 
the regression model repeated the non-significant findings, thus disconfirming the fourth 
hypothesis. 
Next, stepwise regressions were performed to determine what factors had an overall 
influence on levels ofPTSD 1 year post-diagnosis. Two sets ofregressions were 
performed, with either the lES or the PCL-C total scores used as the dependent measures. 
In order to predict PTSD symptoms at time 4 the following time 1 variables were entered 
in a linear regression: PTSD (either on the lES or the PCL-C) was controlled first, and 
th en depression, anxiety, quality oflife and perceived stress were entered in the model. 
For the cancer group, the model using the lES time 4 as the dependent variable revealed 
depression as a significant predictor of lES at time 4 once lES at time 1 was controIled, 
~ = .31, t(53) = 3.0,p < .01. The model generated a reasonable fit (Adjusted R2= 0.55) 
and the overall relationship was statistically significant (F (2, 53) =35.253, p<O.OOO). 
Apart for a significant effect of depression at time 1 on lES levels at time 4 for the cancer 
group, depression, anxiety, quality oflife and perceived stress were aIl non-significant 
once the initiallevels ofPTSD (either on the lES or PCL-C) was controlled. For the 
control group, only the lES at time 1 was a significant predictor of the lES at time 4. It 
accounted for 31.4% of the variance (F (1, 64) =30.776, p<O.OOO). In the model using the 
PCL-C at time 4 as the dependent variable, only the PCL-C at time 1 was significant 
predictors for the cancer groups (Adjusted R2= 54.5%). For the control group, only the 
PCL-C at time 1 was a significant predictor of the PCL-C at time 4 (Adjusted R2= 
30.3%). 
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A set of logistic regressions were performed to explore whether previous exposure to 
trauma had an impact on PTSD scores at time 4. The presence of previous exposure to 
trauma was coded as present or absent, this represents the independent variable. The. 
presence of PTSD at time 4 on the lES and the PCL-C was dichotomized as present 
(moderate to severe symptoms) or absent (none or low levels of symptoms), this was the 
dependent variable. Two sets of logistic regressions were performed, one for the cancer 
patients, and one for the control group. For the cancer patients, those who were exposed 
to a prior traumatic event, marginally significant results point to the possibility that they 
were about 3 time more likely to have CUITent PTSD on the lES at time 4 than those who 
were not exposed Exp(B)=3.426 (1,56) p<0.08. The effect ofprevious exposure to a 
traumatic event did not have a significant effect on CUITent PTSD scores for the control 
groups on the lES. The effect ofprevious exposure to trauma on the PCL-C was not 
significant for neither of the groups. 
In summary, variables which share a relation with PTSD, such as perceived stress, 
quality oflife, and anxiety, do not predict PTSD when early levels ofPTSD are 
controlled. For control s, only previous measurements ofPTSD were significant 
predictors ofPTSD at time 4. The bulk of the variance in predicting the PTSD scores at 
time 4 is taken up by original PTSD scores at time l, which is consistent with our second 
hypothesis (once PTSD symptoms arise they tend to persist over time). Analyses of 
covariance (ANCOVA) revealed that once levels ofPTSD on the lES and PCL-C at time 
1 were controlled; there was still a significant difference between the cancer and the 
control group at time 4 on these same measures ofPTSD. Groups were significantly 
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different on the lES at time 4 when lES at time 1 was controlled F=4.311 (1, 125) p<0.04 
and on the PCL-C time 4 when the PCL-C time 1 was controlled F=4.602 (1,120) 
1 9 p<0.03 . 
Discussion 
The objectives ofthis study were to determine the frequency of cancer-related of 
PTSD symptoms in young male cancer patients, to understand how symptoms of cancer-
related PTSD evolved in the first year following cancer diagnosis and to identify risk 
factors that were predictive ofPTSD symptoms. Findings ofthis study paralle1 previous 
reports of PTSD in cancer patients (Cordova et al., 1995) and provide further support for 
the applicability of the PTSD construct to the cancer diagnoses. As was predicted, the 
cancer patients had significantly greater PTSD symptom severity than the controls at 
every time point on both the PCL-C except at time 1 and had higher levels of PTSD than 
controis at time 2 and 4 on the lES. At time 1 there was no difference between the cancer 
and control groups on both measures of PTSD. At time l, the patients had not yet started 
their chemotherapy or radiotherapy treatments and this perhaps explains why they had no 
PTSD-like symptoms regarding the cancer experience. Howéver, they had a higher 
anxiety level than the controls, also perhaps related to the fact that treatments were not 
yet started and patients had much uncertainty about what to expect in terms of medical 
procedures. This may also be due to a sensitization to the measure for controls, making 
them evaluate past stressors as salient, or may also be due to the fact that about one 
quarter of the controls were dealing with a recent diagnosis of infertility. 
9 Results for the log-transfonned data on the IES and PCL-C produced outcomes that were comparable in 
significance and effect size. 
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Overall, there was a lower incidence of PTSD in this study than that which is found in 
war exposure (18 to 54%) (Oei, Lim, & Hennessy, 1990) or in rape victims (16 to 60%) 
(Resnick, Kilpatrick, Dansky, Saunders, & Best, 1993). However, PTSD symptom 
severity was either comparable or slightly lower than that of other cancer populations. 
Mean scores on the PCL-C for cancer patients in this study ranged from 26.66 to 29.87 
for the final sample and from 26.96 to 31.25 for the cross-sectional data. These result,s are 
very similar to results reported in a cross-sectional study ofbreast cancer survivors who 
had a mean of 27.1 (SD= 12.7) on the PCL-C (Cordova et al., 1995). In our study, the 
percentage of cancer patients who could be considered as fitting the DSM-IV criteria for 
PTSD (PCL-C score of 50 and above) ranged from 3.4% to 8.3% (cross-sectionàl 
sample) from time 1 to 4. In a sample of 82 breast cancer survivors (mean age: 56.6; 
mean of 37 months post-treatment), there was a 5% prevalence of CUITent PTSD related 
to cancer on the PCL-C (eut-off score of50 and above) (Andrykowski et al., 1998). 
However, subsyndromal (eut-off of 40 and above) frequency ofPTSD had a range 13.6 to 
22.2% in our study (cross-sectional scores), which is at least two-fold that of controls at 
time 2 to 4. 
Mean scores on the lES for cancer patients ranged from 14.78 to 17.97 for the final 
sample and 16.24 to 20.98 for the cross-sectional data. Two distinct studies ofbreast 
cancer survivors reported means of 16.4 (SD=18) (Cordova et al., 1995) and 31 
(SD=14.6) (Butler et al., 1999). In this study, there was between 7% and 14.3% of cancer 
patients who had severe symptoms, and between 21.2% and 34.9% who had moderate to 
severe symptoms on the lES (cross-sectional scores eut-off of above 26). This is 
substantially lower than reports from breast cancer survivors. Butler et al. (1999) using a 
eut-off score of 30 reported that 52% of the survivors scored in the severe range category. 
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Our findings are significantly lower than one study ofbreast cancer survivors (Butler et 
al., 1999), which is consistent with the literature suggesting higher incidence in females 
that males (Kangas et al., 2005a, 2005b; Olff et al., 2007). These differences could be due 
to the worse prognosis associated with breast cancer, but are perhaps illustrative of 
gender differences in the frequency of PTSD symptoms. 
In terms of the evo1ution ofPTSD sympfoms over the first year since diagnosis, 
there was a significant effect for the group X time interaction; only the control 
participants experienced a decrease in symptoms over time. The cancer patients had- a 
higher and increasing level of PTSD symptoms over time. This finding is inconsistent 
with previous longitudinal studies that reported the highest level of cancer-related PTSD 
at the time of diagnosis followed by a graduaI decline over time (Kangas et al., 2005a, 
2005b, 2005c, 2005d; Manuel et al., 1987). Also, the CUITent study pointed to the 
pervasiveness of early PTSD symptoms. 
Depression scores increased for the cancer patients from time 1 to time 2 but th en 
decreased significantly from time 2 to time 3. Anxiety scores did not fluctuate over time 
for neither the cancer group nor the control group. Depression and anxiety scores also 
tended to be higher for cancer patients than the controls. Contrastingly, there was no 
group difference for perceived stress and for quality oflife. 
These results point to the distinctive nature of PTSD responses in cancer patients 
wh en compared to adjustment in terms of general stress or quality oflife. Cancer patients 
expressed the same level of general stress and health-related quality of life as a sample 
composed mostly of college students and infertile males; however their symptoms of 
PTSD were in every case more elevated. Our results suggest that cancer patients are not 
overall worse offthan healthy controls, and that this is not an undifferentiated effect on 
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every measure of psychosocial adaptation. While they are experiencing higher levels of 
depression and anxiety than controls, these symptoms decrease over time, but PTSD do es 
not. This brings about questions conceming measurement and meaning of PTSD 
symptoms in cancer patients. 
Measurement of PTSD is limited by the instruments that were employed. While the 
lES asks about the frequency of intrusive thoughts and avoidance, the lES do es not assess 
whether these experiences are actually distressing for the patient. Whether these 
symptoms result in impairment, problematic ruminations and di stress is unclear. 
However, the use of the PCL-C as a second instrument to assess PTSD symptoms did 
take di stress into account. In this study, incidence rates of cases of moderate to severe 
PTSD symptoms were consistently lower on the PCL-C than on the lES. It could possibly 
be that a certain proportion of individuals score high on the lES but not on the PCL-C as 
they may be experiencing sorne cognitive symptoms but are not distressed about them. 
One possible way ofunderstanding the data is by introducing the concepts of 
cognitive integration and processing. Certainly, thinking about an experience is not 
problematic in itself; it may ev en be beneficial in terms of cognitive integration. Perhaps 
the high correlations and predictive value of depression on PTSD can indicate that these 
symptoms are in fact distressing for a number of patients for sorne time, but perhaps not 
aIl. As anxiety and depression wane over time and PTSD ~ymptoms increase, it may be 
the case that PTSD symptoms are not as distressful as expected in a clinical sense, but 
may represent a form of cognitive processing. As seen in our study, cancer patients did 
not differ from control participants in terms of quality oflife or perceived stress. 
A voidance may be adaptive in the face of immediate trauma, but may become counter-
productive ifit goes on for too long (Brennan, 2001; Foa, Stekee, Rothbaum, 1989; 
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McMillen, North, Smith, 2000; SuIs & Fletcher, 1985). Efforts not to think about the 
event prevent individuals from elaborating the trauma memory and linking their 
experience with its context in time, space, previous and subsequent information and other 
autobiographical memories. Such efforts also prevent changes in appraisals. 
Reconstruction emphasizes on what is unchanged by the experience, incorporation 
recognizes the opportunity offered by the experience to develop and expand a pre-
existent facet of identity (Little, Paul, Jordens, Sayers, 2002). It is possible that the search 
for meaning, through cognitive processing of the experience, allows acceptance and 
incorporation (Little et al., 2002). Reminiscence ofthe traumatic event may lead to 
positive reappraisals or may lead to the integration ofthe new experience in the existing 
set ofbeliefs of the individual (Brennan, 2001). In the CUITent study, there was a 
significant increase in intrusion score froIJ1 time 3 to time 4, but there were no significant 
changes in avoidance scores over time for the cancer group. Positive appraisals and 
reappraisals of a traumatic event have been linked to faster cortisol habituation to 
subsequent stressors, indicating a greater flexibility in the system. Positive reappraisal of 
the trauma may therefore serve as a protection against developing PTSD (Epel, McEwen, 
& Ickovics, 1998). 
Contrary to expectation, demographic variables did not predict any significant 
variance in PTSD symptoms. Except for a correlation with the PCL-C at time 1, the 
SRSS was unrelated to aIl measures at aIl time points for th~ controls. Also contrary to 
prediction, history of trauma was uncoITelated to the lES, the PCL-C, depression and 
anxiety scales for the controls, and only cOITelated to depression at time 1 for the cancer 
patients. However, in the logistic regressions exposure to a prior traumatic event 
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increased the likelihood to have current PTSD on the lES for cancer patients but not for 
controls. 
There is certainly an important relation between depression and PTSD for cancer 
patients on the lES, which remains significant when early levels ofPTSD are controlled 
as in this study. Variables which share a relation with PTSD, such as perceived stress, 
quality oflife, and anxiety, do not predict PTSD when early levels of PTSD are 
controlled, or when depression levels are controlled. The nature of this association has 
been brought into question in light of studies reporting correlations between depression 
and PTSD as high as r=0.70 p<O.OOI (Epping-Jordan et al., 1999; Neria & Bromet, 
2000). The overlap in measurement of depression, anxiety and PTSD produces 
quantitatively high collinearity. Because concepts such as intrusions resemble anxious 
thoughts about the future, and depressed mood may resemble numbing, qualitative work 
is needed to clarify this relation. 
One ofthe limitations ofthe study is the voluntary and non-random recruitment of the 
participants. The conclusions of this study are limited by our sample size. Failure to 
demonstrate a difference between groups or between time points may be due to lack of 
statistical power. Moreover, patients dropping out of the study limited the power of 
longitudinal analyses by reducing the sample size ev en further. Data replacement cannot 
be performed to replace entire time points for those who missed an assessment. When 
reporting longitudinal analyses, only complete,cases can be used, or it is impossible to 
make an argument for the effect oftime. Missing data was problematic as analyses need 
to be done on the same individuals through time. Also there was a low variability in age, 
marital status and education; the sample may not be representative of the population. 
Furthermore, the healthy control sample was heterogeneous with regard to being 
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composed of infertile men and men from the general community. The community 
controls self-identified a stressful event in their past. The time elapsed since the given 
event was on average three to four time the amount oftime elapsed at each time point 
since the cancer diagnosis of the patient group 10, which means that their PTSD scores 
might have been lowered by the effect oftime. Ideally, cancer patients would be 
compared to a group ofmen recently diagnosed with a homogenous non-life threatening 
condition to compare the outcomes in both groups. Another limitation concems the 
measurement of stressful life events on the SRRS which were only measured at time 4. 
Future research could attempt to measure stressful life events in the year preceding the 
first assessment. This would allow controlling baseline differences between groups on the 
basis ofrecent life stress. Future research could also attempt to measure personality 
characteristics associated with PTSD which would allow speaking about individual 
differences in the development ofPTSD. As frequency ofPTSD-like cases in our sample 
were similar or a bit lower than what was presented in other studies, and given the great 
variability in reported prevalence in the literature (Kangas et al., 2002) meta-analyses 
would be needed to make further conclusions. Finally, a de"eper study of the expression of 
cancer-related PTSD symptoms, in the form of clinical interviews, case studies or 
qualitative studies, would clarify the amount of distress that is associated with these 
symptoms. The lES while being a very frequently used instrument to assess symptoms of 
intrusions and avoidance do es not assess whether these symptoms are accompanied by an 
impaired functioning and di stress following the stressful event. Future studies would 
10 At time 1, the mean number of months elapsed since diagnosis for cancer patients was 1.88 months, 5.44 
months at time 2, 8.68 months at time 3 and 14 months at time 4. For control participants, the mean number 
of months elapsed since their reported stressful events was 26.16 months at time 1, 37.03 months at time 2, 
37.96 months at time 3 and 40.99 months at time 4. 
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benefit from using diagnostic tools such as semi-structured clinical interviews and more 
research is needed to determine whether symptoms ofPTSD are maladaptive (i.e.: 
prolonged avoidance). Self-efficacy and appraisal ofsymptoms (not of the event itself) 
may be good indicators of who may develop higher di stress. 
Conclusion 
Cancer-related PTSD can be observed in a minority of cancer survivors, which indicates 
a fairly good adjustment for most cancer patients. The cancer experience is a stressor on a 
chronic basis, disruptions of normal functioning are present from diagnosis and may 
persist over the long-term remission phase. As a retum to health gradually takes place, 
depression and anxiety symptoms wane, but PTSD symptoms remain stable. Wh ether 
these symptoms are associated with decreased functioning or are an expression of 
cognitive integration of the experience is yet to be investigated. Health care workers can 
gain by understanding factors and moments in which patients are more psychologically 
fragile. This would allow them adapt their practice so that care will be provided more 
efficiently to those who are most in need of it. 
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Tables 
Table 1 
Sociodemographic characteristics of sample 
Cancer n Cornbined n 
patients controls 
Age 
Mean 27.3 92 26.9 88 
Standard deviation 6.71 6.66 
Median 26 26 
Range 16-50 18-46 
First language% 
French 33.7 31 34.1 30 
English 50 46 29.5 26 
Other 16.4 15 36.4 32 
Marital status% 
Single 62 57 67.1 59 
Married 19.6 18 20.5 18 
DivorcediSeparated 3.3 3 6.8 6 
Common law 15.2 14 4.5 4 
RefusaI/no answer 0 0 l.l 1 
Parental status % 
Children 10.9 14 6.8 6 
No Children 83.7 77 93.2 82 
RefusaI/no answer l.l 1 0 0 
Education% 
Sorne high school 14.1 13 4.5 4 
Cornpleted High School 17.4 16 6.8 6 
Sorne College 21.8 20 5.7 5 
Sorne or cornpleted University 46.8 43 83 73 
Ernployrnent % 
Full-tirne 55.4 51 33 29 
Part-tirne 5.4 5 13.6 12 
Ternporarily not working 12 Il 4.5 4 
Unernployed 7.6 7 2.3 2 
Student 17.4 16 44.3 39 
At home l.l l.l5 1 
RefusaI/no answer l.l l.l5 1 
lncorne% 
Less than $20 000 14.1 13 28.4 25 
20 to $39 000 17.4 16 19.3 17 
40 to $59 000 25 23 12.5 Il 
60 to $79 000 6.5 6 2.3 2 
80 to $100 000 8.7 8 5.7 5 
More than $100 000 13 12 15.9 14 
RefusaI/no answer 15.2 14 15.9 14 
Table 2 
Previous exposure to a traumatic event 
Table 3 
Cancer patients 
Combined Contrais 
Total 
Previous trauma 
18.5% (n=17) 
26.2% (n=23) 
(n=40) 
PTSD symptoms severity frequencies per group 
Time 1 Time2 
Cancer Combined Cancer 
patients contrais patients 
lES 
N 92 88 63 
None 26.1% 47.7% 31.8% 
Mi1d 39.1% 31.8% 33.3% 
Moderate 26.1% 14.8% 20.6% 
Severe 8.7% 5.7% 14.3% 
PCL-C 
N 88 88 63 
None 86.4% 87.5% 78% 
Moderate 102% 9.1% 15.9% 
Severe 3.4% 3.4% 6.3% 
No previous trauma 
81.5% (n=75) 
73.8% (n=65) 
(n=140) 
Time3 
Combined Cancer 
contrais patients 
76 71 
65.8% 32.4% 
18.4% 46.5% 
14.5% 12.7% 
1.3% 8.5% 
76 72 
96.1% 83.3% 
0% 8.3% 
3.9% 8.3% 
Total n 
(n=92) 
(n=88) 
(n=180) 
Combined 
contrais 
67 
61.2% 
20.9% 
16.4% 
1.5% 
67 
92.5% 
6% 
1.5% 
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Time4 
Cancer Combined 
patient controls 
57 66 
42.1% 62.1% 
33.3% 22.7% 
17.5% 13.6% 
7% 1.5% 
58 66 
79.3% 90.9% 
17.2% 6.1% 
3.5% 3% 
LEGEND: IES scoring: 0-8 none; 9-25 mild; 26-43 moderate; 44 and+ severe (range 0 to 75) PCL-C scoring: 0-39 none; 40-49 
sub-clinical (moderate); 50 and + severe (range 17 to 85) 
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Table 4 
Summary of intercorrelations between scales for the cancer and control group 
Cancer group Combined controls 
Variables 
Timel Timel Timel Timel Timel Timel Timel. Timel 
lES t1 ,50** ,60** ,64** ,46** ,31 ** ,71·· 
PSS tl .53** ,52·· ,43·· .50·* ,62""" ,56·· .29·· ,46·· 
PCL-Ctl .70** .70·* .64·· ,55** .47** .71** 
Fact QOL t1 -,62** -.45** -.37** -.47·· -.67*· -.48** -31 ** -,43** 
SRSSt4 ,42*· .46** .38· '.51* .19 .22 ,II .29· 
Marital status -.09 -.22* -,01 -.14 -.05 -.09 -, II -.07 
Income -.12 -,26 -,07 -.07 ,01 .02 ,01 -.15 
Parental status -.17 -.23" 12 -.14 .03 -.08 ,06 ,01 
Time2 Time2 Time2 Time2 Time2 Time2 Time2 Time2 
lES t2 .62** ,66"* ,85·" .42"" ,30"" .60·" 
PCL-Ct2 .75"" .73** ,85"* .51 * ,57** .60** 
SRSSt4 ,40· .31 ,24 .34· .16 .12 .14 .04 
Time3 Time3 Time3 Time3 Time3 Time3 Time3 Time3 
lES t3 .63·· .68** .78·· .57** ,49** .78*· 
PSS t3 .79** .69·· .50·· .70·· .65·· ,58** ,46·· ,50·· 
PCL-Ct3 ,76·· .78·· .78·· .65** .65·· .78·· 
Fact QOL t3 -,84·· -.70·· -.61·· -.77·· -,70·· -.55·· -31· -,40·· 
SRSSt4 -,01 -.01 .13 .16 .28· .23 .08 ,08 
Income -.23 -J2 -.17 -,25 -.18 -.08 -,11 -,02 
Time4 Time4 Time4 Time4 Time4 Time4 Time4' Time4 
lES t4 ,62·· .65·· ,85·· ,44** ,52·· ,81·· 
PSS t4 .82·· ,71·· ,49*- .68""" ,55** ,56·· .27· ,31-
PCL-Ct4 .75·· .78·· .85·· .58·· .65"'· ,81 ** 
Fact QOL t1 -,85·· -,73** -,62** -,79·· -.58·· -.60·· -.35·· -,47·· 
SRSSt4 .53·· ,41·· ,26 JO ,II .14 -,02 .15 
Age -.28* -.23 .04 -.04 -,05 .10 ,]3 .13 
LEGEND: DEP= SCL-90 depression score; ANX: SCL-90 anxiety scores; lES: impact ofevent scale total 
score; PCL-C: posttraumatic checklist-civilian total score; SRSS= Social Readjustment Stress Scale; Fact-
') QOL: Quality oflife 
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APPENDIX 1: Events reported as history of exposure to trauma tic events 
Coded as traumatic: 
Car accident 
Witnessing an explosion in Israel 
Plane ride through a storm with lots ofturbulenee 
Armed thief stole car 
Mugged at knife point 
Hit be a car while on roller bladeslbikel walking 
House being robbed while still inside the house 
Being kidnapped along with friends 
Heart attack or stroke 
Suspended in the air of an elevator shaft on the Il th floor 
Caught in a rock slide on a mountain 
Bank robbery witness 
Armed robberylbeing held at gun point in a store 
Attacked by a man with a metal bar and being hit across the head 
Severe chocking on food, couldn't breathe 
Past cancer diagnosis 
. Being a UN representative in Iraq in 1995-1996 and being caught in a 
cross-tire 
Was in Kuwait when invasion started 
Coded as non-traumatic: 
Father died from natural causes: 
Separated from wife, romantic partner 
Could have drowned 
Benign tumour 
Injury during a hockey game 
Attempted suicide in 1996 and 2000 
Epileptic episode 
Almost had a motorbike accident 
Witnessed a car accident of strangers 
Mother in law broke her baèk 
Girlfriend's mother was diagnosed with cancer 
Diagnosed with diabetes 
Iee climbing 
Being in a physical tight 
Frequency 
13 
1 
1 
1 
6 
4 
1 
1 
2 
1 
1 
1 
2 
1 
1 
1 
1 
Frequency 
2 
2 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
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APPENDIX 2: Characteristics of drop-outs vs. completed sample 
Table 5 
Characteristics ofdrop-outs vs. completed sample 
Cancer group 
Mean STD t 
Age Drop-out 26.7 7.1 -.87 
Complete 27.97 6.2 
Complete 1.7 .48 
Intrusions tl Drop-out 10.7 8.2 2.19 
Complete 7.1 6.5 
Avoidance t1 Drop-out 11.5 7.9 1.69 
Complete 8.5 8.7 
IES t1 Drop-out 22.2 14.7 2.18 
Complete 15.7 13.0 
PSS t1 Drop-out 25.3 6.3 1.29 
Complete 23.3 8.1 
PCL-C t1 Drop-out 28.98 9.0 1.22 
Complete 26.7 8.6 
Depression t1 Drop-out 62.9 10.1 1.77 
Complete 58.7 12.4 
Anxiety t1 Drop-out 60.8 11.1 1.26 
Complete 57.7 12.2 
Fact qol t1 Drop-out 77.98 14.4 -1.49 
Complete 82.5 13.7 
Table 6 
Retention per time point and drop-out motives 
cancer 
Time 1 completed 92 
Time2 completed 63 
Time 3 completed 71 
Time4 completed 57 
AlI time points completed 38 
Drop-outs Did not receive 19 
time 2 
deceased 
Ineligible 
Drop-out 
Not yet 
reached a time 
. point 
df 
89 
90 
90 
90 
89 
86 
90 
90 
90 
Sig 
p< 
.38 
.03 
.09 
.03 
.20 
.23 
.08 
.21 
.14 
4 
2 
6 
23 
Control group 
Mean STD 
28.2 7.54 
26.3 6.20 
1.4 .5 
5.9 7.7 
6.8 8.8 
6.3 8.2 
7.3 8.3 
12.2 15.4 
14.1 15.6 
22.1 7.7 
21.3 6.9 
25.2 14.3 
25.2 9.5 
53.4 11.6 
54.7 11.2 
49.2 10.8 
51.1 10.6 
87.8 11.0 
86.1 10.7 
Control 
88 
76 
67 
66 
61 
t 
1.25 
-.44 
-.52 
-.51 
.50 
.01 
-.51 
-.78 
.68 
24 
3 
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df Sigp< 
86 .22 
86 .66 
86 .61 
86 .61 
86 .62 
86 .997 
86 .61 
86 .44 
86 .50 
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Attrition details 
At time 2, there were 63 cancer patients who completed the study, there were 17 
cancer patients did not receive time 2 (time 2 started sorne months after the beginning of 
initial recruitment, hence sorne of the first participants did not receive time 2), 2 were 
unreachable by phorie after 3 attempts, 3 deceased, 2 dropped out (didn't want to pursue), 
2 were ineligible (1 wasn't going to receive chemo, 1 was too ill to pursue the study), and 
3 had no data available for that time point because they had not reached that 
measurement point yet (recently entered the study). There were 76 controls that fi Il éd 
time 2. Of those missing, one did not receive time 2 (but complete further'time points), 3 
were unreachable by phone at time 2, 5 dropped out, 3 had no data available yet for that 
time point. Of those who were unreachable, 2 filled out time 3 and 4, and one filled out 
only time 4. 
At time 3, there were 71 cancer patients who completed the study. Out of the total 
initial sample (92): 1 missed his scheduled appointment for the study at time 3 (but filled 
time 4),5 dropped-out, 4 deceased, Il had no data yet available for that time point. 
There were 67 controls that filled time 3, 1 remained unreachable (but filled time 4) 16 
participants dropped out (mostly infertile controls, one moved away to another 
continent), 1 missed his scheduled appointment (but filled time 4), and 3 had not yet 
reached that -time point. At time 4, 57 cancer patients completed the questionnaires. Of 
the total initial sample (92), 2 were ineligible, 6 participants who dropped out of the 
study, 4 deceased and 23 had not reached that time point yet. 
When considering the total number of individuals that were available from the initial 
sample to complete time 4 (not counting those who had not yet reached that measurement 
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point, those who passed away, or ineligible), the retenti on rate in the study for cancer 
patients was 87.7%. There were 66 controls that filled time 4. From the total initial 
sample (88), 19 dropped-out and 3 had not yet reached that time point. When 
considering the total number of individuals that were available from the initial sample to 
complete time 4 (not counting those who had not yet reached that measurement) the 
retenti on rate in the study for controls was 77.6%. As such, at time 4 there were 38 
cancer patients (38/46 response rate of available candidates who filled all time points is 
82.6%- considering that 17 were not even exposed to time 2, 23 had not reached the end 
of the study, 2 were ineligible and 4 deceased)- and 61 controls (response rate of 
available candidates who filled aIl time points is - 72.6% considering that 1 had not been 
exposed to time 2 and 3 had not yet reached the end of the study) who had filled out all 
four time points (hereafter called the final sample). 
APPENDIX 3: Events reported by controls on the lES and PCL-C at time 1 
Coded as traumatic: 
Car accident 
Head injury bike accident 
House robbery 
Kidnapped/mugged 
Heart attack 
Robbed at knife point 
Caught in a gun tire . 
Suspended in the air in an elevator shaft for hours on the Il th floor 
Bank robbery 
Armed robbery 
Coded as non traumatic: 
Schoolwork, exams 
Dog died 
Failed exam, failed a c1ass 
Death of hamster 
Relationship breakup/separation/divorce 
Benign tumor 
Meeting with supervisor 
Girlfriend is away 
Fired from job 
Death of a relative 
Psychotic episode 
Parents' ill health 
Announcing homosexuality 
Anxietyattack 
Attempted suicide 
Epileptic seizure 
Blushing in public 
First witness to a car accident 
Student strike 
Trip to Nicaragua 
Disqualified from an international regatta 
Threat of fine for violation of copyright 
Applying to grad school, school choices 
Lost pas sport 
Plane ride 
New job, job search 
Verbal fight 
Moving to Montreal 
Frequency 
5 
1 
1 
1 
1 
1 
Frequency 
7 
1 
2 
1 
9 
1 
1 
1 
1 
4 
1 
3 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
2 
1 
1 
2 
1 
1 
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Additional events reported at other time points l 
Coded as trauma tic: 
Attacked by a gang of 6 men 
Motorized vehic1e accident 
Mugged at knife point 
F ell down a dam 
House robbery 
Being physically assaulted 
Coded as non traumatic: 
Major misunderstanding 
Putting out a large camp tire 
Broke a 1eg, psychical injury 
Starting university 
Travelling alone in Europe 
Hit by drunk mother 
Heard the news about a friend being raped 
Job search 
Relationship break up 
School work, Exam period 
Graduation 
Feeling depressed 
Problem accessing government loans 
Frequency 
1 
4 
1 
1 
1 
1 
Frequency 
2 
1 
2 
1 
1 
1 
1 
1 
2 
5 
1 
1 
1 
1 These events represent a change from previously reported events either from none reported or from 
another event previously reported. 
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SECTION 4: GENERAL CONCLUSION 
General Summary 
The combined objectives of the present studies were: to explore the cancer related 
symptoms ofPTSD and distress (specifically symptoms of depression and anxiety); to 
determine the frequellcy of PTSD symptoms in young male cancer patients; to assess the 
evolution of PTSD symptoms in the first year following a cancer diagnosis as they relate 
to risk factors predictive ofPTSD symptoms; and to examine the coping and 
posttraumatic growth experiences of survivors. 
The susceptibility to PTSD symptoms in patients with cancer is supported by the results 
ofthis research project. From the results of the qualitative study (Study 1), we observed 
that the initial reaction to the diagnosis of cancer is one of anxiety, the reaction during the 
treatment phase is one of depressed affect and the reaction in the post-treatment phase is 
a combination of PTSD symptoms and integration of the experience through cognitive 
processing. In a paper about the cognitive model ofposttraumatic stress disorder (Ehlers 
& Clark, 2000) the authors mention that the possibility of loss is associated with anxiety, . 
whereas the certainty of loss is associated with depression. In study l, anxiety was 
closely tied to the period following diagnosis and depression was frequent during the 
treatment phase. In the qualitative study, the intrusive thoughts reported by survivors at 
diagnosis and treatment strongly resembled anxious worries about future threats while 
intrusions reflecting past experience (the impression of seeing cancer everywhere, 
thinking about cancer when they did not mean to) only appeared post-treatment. The 
results presented in this study illustrate the many anxious worries about the future that 
patients experience: the fear of death, the unknown nature of treatments, possible 
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complications and side-effects. These anxious worries resemble the intrusive symptoms 
of PTSD, but they are related to preparing oneself to respond to a future threat rather than 
the recurrent thoughts about a past trauma, as is more typical ofPTSD. As described 
elsewhere (Mundy & Baum, 2004), the worries in patients diagnosed with a life-
threatening illness may be more future-oriented than focused on the past. In the present 
study, it is only in the long-term survival phase that intrusions made their appearance, 
thus earlier observations may be more characteristic of anxiety. More survivors reported 
the presence of PTSD symptoms, such as high intrusions, avoidance, hypervigilance and 
emotional numbing in the post-treatment phase. Still, many survivors reported a general 
good adjustment and posttraumatic growth. 
The quantitative study (Study 2) revealed significantly greater PTSD symptom 
severity in cancer patients as compared to controls at every time point on the PCL-C 
except at time one, and had higher scores on the lES at times 2 and 4. The effect 
remained stable when PTSD symptom severity at time 1 was controlled. In 
contradistinction, scores of depression and anxiety, which were initially elevated for the 
cancer patients, decreased over time, while remaining consistently at low levels for the 
controls. Other indicators ofwell-being failed to identify a difference between groups. 
There was no group difference in perceived stress or quality oflife. 
In terms of the evolution of cancer-related PTSD symptoms, both studies pointed 
towards an initially low level of PTSD with either stability or an increase over time. 
There was, however, a significant decrease in symptoms for the control group 
participants. This finding contradicts previous longitudinal studies that report highest 
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levels of cancer-related PTSD symptoms at the time of diagnosis followed by a graduaI 
decline over time (Kangas et al. 2005a, 2005 b, 2005c, 2005d; Manuel et al. 1987). 
Lazarus and Folkman's (1984) Transactional Coping Theory views appraisal as 
preceding coping and involves both primary and secondary appraisal processes. In 
primary appraisals, individuals assess events as threats, losses, challenges, benefits, or as 
irrelevant. Challenges are defined as opportunities for improvement. However, in the case 
of traumatic stress, it is less likely that events will be defined as opportunities for 
improvement, with the exception perhaps ofbeing faced with a chronic illness such as 
cancer (Mundy & Baum, 2004). These positive reappraisals of the cancer diagnosis from 
being a threat to a challenge may be at the root of posttraumatic growth. 
It is possible that the search for meaning, through cognitive processing of the 
experience, allows acceptance (Little et aL, 2002). The perceived threat motivates a series 
ofbehavioural and cognitive responses that reduce the threat and di stress in the short-
term. A voidance may be adaptive in the face of immediate trauma (Ehlers & Clark, 
2000), but has the consequences of preventing cognitive change and therefore 
maintaining the disorder in the long-term (Ehlers & Clark, 2000). Efforts not to think 
about the traumatic event prevent individuals from elaborating the trauma memory and 
linking their experience with its context in time, space, previous and subsequent 
information and other autobiographical memories (Brennan, 2001; Foa et aL, 1989; 
McMillen et al., 2000; SuIs & Fletcher, 1985). They a1so prevent changes in appraisa1s. 
The presence of growth does not necessarily signal an end to pain or distress, and 
usually it is not accompanied by a perspective that views the crisis, 10ss, or trauma itse1f 
as desirable. Many persons facing devastating tragedies do experience growth arising 
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from their struggles, but only the growth is desirable, not the tragedies themselves 
(Tedeschi & Calhoun, 2004). Both positive and negative outcomes can occur, either 
simultaneously or sequentially, in the same individual. Virtually every cancer patient who 
reports posttraumatic growth also reports sorne distress. Survivors must relinquish sorne 
pre-illness goals and basic assumptions and attempt to build new ones at the same time. 
Survivors re-construct their identities in ways that accommodate the experience and its 
sequelae, that is, they resume a version of their former lives but they incorporate aspects 
of their illness experience into their lives (Little et al. 2002). 
The coping pro cesses taking place also influence the cognitive integration of trauma 
and the extent ofposttraumatic growth. For example, the opportunity to talk about the. 
experience of cancer and the presence of social support may be additionally beneficial to 
cognitive processing and may help through the provision of altemate schemas (Tedeschi 
& Calhoun, 2004). In contrast, individuals who are remarkable in hardiness, possess a 
high sense of coherence and who are highly resilient, may not be challenged sufficiently 
by the traumatic event to enter a pro cess of revaluation of existing schemas (Tedeschi & 
Calhoun, 2004). In our study, sorne survivors mentioned coping by staying active which 
might reflect an attempt to preserve assumptions about the self. In contrast, personality 
characteristics such as optimism, extraversion and openness to experiences, which allows 
for a flexible re-evaluation of assumptions, may make posttraumatic growth more likely 
(Tedeschi & Calhoun, 2004). 
Thè present research has numerous strengths. First, the use of triangulation, through a 
combination ofinvestigative methods (qualitative analysis, theoretical integration and 
quantitative analysis) allowed for a retrospective and prospective account of cancer 
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related-PTSD symptoms. Additionally, the presence of a qualified interviewer in both 
study 1 and study 2, ensured unifonnity in test-taking conditions within each study. The 
qualitative infonnation allowed for an initial exploration of the singular expression of 
PTSD symptoms in cancer patients. Prospective data collection helped reduce recall bias 
often present in retrospective measures and the inclusion of more than one questionnaire 
on PTSD allowed a better coverage of the construct. Furthennore, the use of 
complimentary statistical analyses (correlations, linear regressions, repeated measure 
ANOVAs, ANCOVAs, chi-squares and logistic regressions) strengthened the conclusions 
ofthis study. Combined altogether, this rich data provides a novel and integrated 
understanding of the development ofposttraumatic reactions from diagnosis to long-tenn 
recovery. 
Limitations 
One of the limitations of the study is the voluntary and non-random reèruitment of the 
participants. The results of these studies may not generalize to other cancer populations 
of young males, to female cancer patients, or to older patients. There was a low 
variability in age, marital status and education; sample may not be representative of the 
population. The sample recruited in this study was very homogeneous. The men in our 
study were aIl Caucasian; the majority was employed full-time and earned a higher 
income than most Canadians. 
In the qualitative study, it is possible that men whower~ most concerned by fertility 
issues were those who accepted to participate in the study. Generalizations are restricted 
by the large amount oftime elapsed between post-treatment and data collection. 
Survivors resume to a version of their fonner lives within the context of cpanged 
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identities and new insight (Little et al., 2002). Survivors integrate the cancer experience 
within their self-concept and also reconstruct their self-concept. As survival is clearly the 
main goal, survivors may be expected to experience gratitude, acceptance and satisfaction 
at the thought ofbeing alive (Little et al., 2002). As such, CUITent autobiographical 
memories of the cancer trajectory may be biased by a reconstructed identity. The 
longitudinal component of the project, as presented in study 2, addressed this issue by 
following patients prospectively. 
The conclusions of study 2 are limited by our sample size. Failure to demonstrate a 
difference between groups or between time points may be due to lack of statistical power. 
Moreover, 'patients dropping out of the study limited the power of longitudinal analyses 
by reducing the sample size ev en further. Data replacement cannot be performed to 
replace entire time points for those who missed an assessment. When reporting 
longitudinal analyses, only complete cases can be used, or it is impossible to make an 
argument for the effect of time. Missing data was problematic as analyses need to be 
done on the same individuals through time. Another limitation of study 2 pertains to the 
instruments used that may limit the validity of conclusions. As was mentioned the lES 
does not measure whether symptoms of intrusions and avoidance are associated with 
. impaired functioning and di stress following the stressful events. However, the use of the 
PCL-C as a second instrument to assess PTSD symptoms did take di stress into account. 
In study 2, incidence rates of cases of moderate to severe PTSD symptoms were 
consistently lower on the PCL-C than on the lES. It could possibly be that a certain 
proportion of individuals score high on the lES but not on the PCL-C as they are 
experiencing sorne cognitive symptoms but are not distressed about them. These 
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individuals may have symptoms but interpret or reframe them into something that they 
can cope with. 
Directions for future research 
As frequency ofPTSD symptoms in our sample was similar or modestly lower than 
other studies, and given the great variability in reported prevalence in the'literature 
(Kangas et al., 2002) meta-analyses are needed to make further conclusions. Future 
studies should also investigate closely the possible gender difference in trajectory of 
PTSD symptoms. Longitudinal analyses did not reveal a trend towards a decline in PTSD 
symptoms in this male sample, while earlier studies of PTSD in female or mixed gender 
samples reported a rapid decline in symptoms in the months following diagnosis. Future 
research is needed to ascertain whether there is a possible effect of gender on the course 
of PTSD symptoms. 
Future research could attempt to measure stressfullife events at the time of diagnosis. 
This would allow controlling differences between groups on the basis of recent life stress. 
Future research could also attempt to measure personality characteristics associated with 
PTSD which might account for individual differences in the development ofPTSD. 
As other authors have noted, the relationship between distress and posttraumatic 
growth is unclear (Tedeschi & Calhoun, 2004). Sorne researchers have found a positive 
association between perceived benefits of cancer and adjustment (Taylor, Lichtman, & 
Woods, 1984), whereas other researchers have not (Andrykowski et al., 1993; Fromm, 
Andrykowski, & Hunt, 1996). This association needs to be clarified. 
We did not measure coping styles and their impact in a prospective and longitudinal 
manner. Sorne coping styles, like emotional social support, an active and engaged 
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approach to cancer,· and optimism lead to better adjustment in front of uncontrollable, 
life-threatening events such as cancer (Carver et al., 1993; Cuttrona & Russell, 1990; 
Epping-Jordan et al., 1999). Likewise, sorne strategies used to control the impact of the 
event may be maladaptive. Thought suppression through attempts at pushing thoughts 
about the trauma out of their minds will increase the frequency of unwanted intrusive 
recollection (Ehlers & Clark, 2000). Others may try not to think about the event by 
keeping their mind constantly busy, taking drugs, or drinking alcohol (Ehlers & Clark, . 
2000). Future research should endeavour to measure coping styles and their impact on 
canèer-related PTSD symptoms. A study of the expression of cancer-related PTSD 
symptoms, in the form of clinical interviews, case studies or qualitative studies, would 
clarify the amount of distress that is associated with these symptoms. 
Future prospective research should include follow-ups longer than one year to 
document the course of PTSD and distress, and to document the persistence of 
posttraumatic growth and new schemas. It is possible that posttraumatic growth may be 
limited to the early months or years following completion of cancer treatment. This 
information has not yet been documented in the literature. 
Conclusion 
There were only a minority of cancer survivors who experienced heightened levels of 
cancer-related PTSD symptoms. The cancer experience is a stressor on an acute .and 
chronic basis, disruptions of normal functioning are present from diagnosis and may 
persist over the long-term remission phase. As a return to health gradually takes place, 
depression and anxiety symptoms wane, but for sorne survivors PTSD symptoms remain 
stable. Whether these symptoms are associated with decreased functioning or are an 
, 
\ 
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expression of cognitive integration of the experience is to be investigated. This project 
began to describe how initial appraisals of the cancer diagnosis can impact outcomes in 
PTSD symptoms. Sorne patients reappraised the diagnosis as a challenge and as 
something that was manageable, this allowed for a cognitive processing of the threat 
information that was conducive to posttra~matic growth. Health care professionals would 
benefit from an understanding' of the factors and timeline associated with patient's 
distress; this would allow them to adapt their practice and care in order to provide help to 
those most in need of it. 
Since the period following the diagnosis is characterized by shock, distress and 
anxiety, it would be appropriate that the large amount of information that is presented to 
patients be repeated several times by the many professionals who encounter the patient. 
This may alleviate sorne of the stress associated with the unfamiliar processes that will 
order their lives for the months ahead, when the initial diagnosis is reappraised as 
something manageable; a challenge over which one can exercise sorne control, as a 
result, patients may be less likely to experience PTSD symptoms. 
The results of our study suggest that patients are under a significant amount of 
emotional duress especially during the treatment phase. Clinical interventions might be 
an important source of support for patients but perhaps not in this stage. The findings 
from this research support the argument for late psychosocial interventions. In an 
intervention study, researchers found that the group who had received a late intervention 
(8 months post-diagnosis) showed greater declines in intrusive thoughts at 12 months 
post-diagnosis than those who received an early intervention (4 months post-diagnosis) 
(Edgar et al. 1992). This effect may be related to the larger presence of denial and 
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avoidance in the early period following diagnosis, while the need for cognitive 
processing may arise later, once the acute treatment phase is fini shed. 
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